ISMRM 23rd Annual Meeting
& Exhibition • 30 May - 05 June 2015 • Toronto, Ontario, Canada |
|
|
Monday 1 June 2015
Exhibition Hall |
10:45 - 12:45 |
|
|
|
1075. |
3D textural features of
conventional MRI predict survival in childhood
medulloblastoma
Ahmed E. Fetit1,2, Jan Novak2,3,
Simrandip K. Gill2,3, Martin Wilson2,3,
Andrew C. Peet2,3, and Theodoros N. Arvanitis1,2
1Institute of Digital Healthcare, WMG,
University of Warwick, Coventry, West Midlands, United
Kingdom, 2Birmingham
Children's Hospital NHS Foundation Trust, Birmingham,
West Midlands, United Kingdom, 3University
of Birmingham, Birmingham, West Midlands, United Kingdom
There has been an increasing interest in childhood brain
tumour characterisation using non-invasive MR image
analysis methods, such as texture analysis (TA) over the
past decade. However, much of this work focused on
diagnostic classification of tumour types. This raises
the question: If textural features could capture
powerful patterns that aid the diagnosis of tumours, can
they also be used to predict patients’ survival
prognosis? Following diagnosis, determination of
prognosis is an important step in tumour management,
with implications that determine treatment options. In
this regard, the primary aim of this study was to
determine whether three-dimensional TA of conventional
MR images could predict the survival of paediatric
medulloblastoma – the most common malignant brain tumour
occurring in childhood.
|
1076. |
Hyperpolarized 13C
diffusion MRS of copolarized pyruvate and fumarate detects
evidence for increased lactate export in 8932 pancreas
carcinoma cells compared to MCF-7 cells
Benedikt Feuerecker1, Markus Durst2,
Dieter Saur3, Marion I Menzel4,
Markus Schwaiger1, and Franz Schilling1
1Nuclear Medicine, Technische Universität
München, Munich, Bavaria, Germany, 2GE
Global Research, Munich, Germany, 3Internal
Medicine, Technische Universität München, Munich,
Bavaria, Germany, 4GE
Global Research, Garching, Bavaria, Germany
Upregulation of glycolysis in tumors results in
increased lactate concentrations in both intra- and
extratumoral areas, the latter leading to an
acidification of the tumor microenvironment.
Hyperpolarized 13C-labelled metabolic tracers can be
used to probe fast metabolic pathways in real-time,
however little has been known from these measurements
about their presence in intra- or extracellular
compartments. In this study we demonstrated that a
combination of copolarized C-13 labeled pyruvate and
fumarate with ADC measurements holds promise for
localizing necrosis and assessing lactate export rate, a
parameter that has been shown to correlate with tumor
aggressiveness.
|
|
|
Monday 1 June 2015
Exhibition Hall |
10:45 - 12:45 |
|
|
|
1077. |
High spatial resolution DWI
for evaluation of breast tumor early treatment response:
Association of ADC changes with pCR
Lisa J Wilmes1, Wei-Ching Lo1, Wen
Li1, David C Newitt1, Suchandrima
Banerjee2, Evelyn Proctor1, Emine
U Saritas3, Ajit Shankaranarayanan2,
and Nola M Hylton1
1University of California San Francisco, San
Francisco, CA, United States, 2GE
Healthcare, Menlo Park, CA, United States, 3Bilkent
University, Ankara, Turkey
This work measured tumor ADC using a high resolution
reduced field of view diffusion weighted imaging (HR-DWI)
technique and investigated the resultant tumor apparent
diffusion coefficient (ADC) metrics as predictors of
pathologic complete response (pCR) in patients with
locally advanced breast cancer undergoing neoadjuvant
chemotherapy. For early percent change in tumor ADC a
trend of increasing AUC with decreasing percentile ADC
was observed. Additionally, at the early treatment time
point the AUCs for the lower percentile tumor ADC were
higher than for the early tumor volume change.
|
1078. |
Non-Cartesian Compressed
Sensing with Fat/Water Decomposition: Feasibility Study for
High Performance Breast DCE-MRI
Jorge E Jimenez1, Leah C Henze Bancroft1,
Roberta M Strigel1,2, Kevin M Johnson1,
Scott B Reeder2,3, and Walter F Block1,3
1Department of Medical Physics, University of
Wisconsin-Madison, Madison, WI, United States, 2Department
of Radiology, University of Wisconsin School of Medicine
and Public health, Madison, WI, United States, 3Department
of Biomedical Engineering, University of
Wisconsin-Madison, Madison, WI, United States
Successful MR methods must combine capabilities for
rapid acquisition, reliable fat suppression, and
significant data undersampling. We present our
experience in making three MR technologies mutually
compatible: IDEAL signal decomposition, L1-based
compressed sensing (CS) reconstruction, and a 3D radial
trajectory; Vastly undersampled Isotropic Projection (VIPR).
We successfully demonstrate incorporation of IDEAL and
CS to 3D T1-Weighted VIPR breast MRI capable of
providing high isotropic resolution. The addition of CS
markedly improved image quality and SNR. Further study
is necessary to determine the lower limit of the
temporal footprint the method will support.
|
1079. |
Breast DCE with Fat
Suppression: Enabling Quantitative Measurements
Maria A Schmidt1, Eva Kousi1,
Araminta Ledger1, Erica Scurr2,
Cheryl Richardson2, Georgina Hopkinson2,
Elizabeth O'FLynn1, Steven Allen2,
Romney Pope2, Robin Wilson2, and M
Leach1
1CR-UK and EPSRC Cancer Imaging Centre, Royal
Marsden NHS Foundation Trust and Institute of Cancer
Research, Sutton, Surrey, United Kingdom, 2Department
of Radiology, Royal Marsden NHS Foundation Trust,
Chelsea, London, United Kingdom
Breast Dynamic Contrast-Enhanced (DCE) examinations are
usually performed with fat suppression, providing
qualitative enhancement curves. In contrast,
pharmacokinetic modelling often uses spoiled
gradient-echo images and a proton density weighted image
as a reference to calculate T1 values. It would be
desirable to calculate T1 values from fat suppressed
clinical DCE examinations to quantify contrast-agent
uptake in longitudinal studies and to assess parenchymal
enhancement. In this work we introduce a reference image
of low flip angle and a calibration process, and
evaluate the accuracy of T1 values thus obtained. T1
measurements are viable in fat suppressed breast DCE.
|
1080. |
A Quadrant-Based
Quantitative Analysis of Background Parenchymal Enhancement
in Breast MRI
Ella F Jones1, Natalie Hartman1,
Helen Park1, Ania Azziz1, David C
Newitt1, John Kornak2, Catherine
Kilfa1, Bonnie N Joe1, and Nola M
Hylton1
1Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, CA, United
States, 2Epidemiology
and Biostatistics, University of California, San
Francisco, San Francisco, CA, United States
This work presents a systematic quadrant-based analysis
of background parenchymal enhancement (BPE) in 172
patients with BI-RADS 1 (normal) or 2 (benign). The goal
is to investigate if regional variations in BPE will
influence the corresponding qualitative BI-RADS BPE
assessment.
|
1081. |
High-resolution Proton
Density weighted Dixon sequences maximize precision of
breast density measurements
Araminta EW Ledger1, Maria A Schmidt1,
Marco Borri1, Erica D Scurr2,
Julie Hughes2, Alison Macdonald2,
Toni Wallace2, Robin Wilson2, and
Martin O Leach1
1CR-UK Cancer Imaging Centre, The Institute
of Cancer Research and Royal Marsden NHS Foundation
Trust, Sutton, Surrey, United Kingdom, 2Radiology,
The Royal Marsden NHS Foundation Trust, Sutton, Surrey,
United Kingdom
Percent-water (%Water) calculated from Dixon fat-water
separation techniques can provide a volumetric
measurement of breast density, an established risk
factor for breast cancer. In this work, we calculate
breast %Water in repeat volunteer datasets to evaluate
measurement reproducibility from a high-resolution
proton-density (PD) weighted two-point Dixon sequence,
and assess the error arising at lower spatial resolution
and with T1/T2 weighting. %Water measurements from
high-resolution PD weighted sequences are found to be
highly reproducible. Statistically significant
differences in %Water measurement arise at lower spatial
resolutions and with the introduction of T1 or T2
weighting, even with correction for fat/water signal
differences.
|
1082. |
Modelling vasculature and
cellular restriction in breast tumours using diffusion MRI
Colleen Bailey1, Sarah Vinnicombe2,
Eleftheria Panagiotaki1, Shelley A Waugh2,
John H Hipwell1, Patsy Whelehan2,
Sarah E Pinder3, Andrew Evans2,
Daniel C Alexander1, and David J Hawkes1
1Centre for Medical Image Computing,
University College London, London, United Kingdom, 2Dundee
Cancer Centre, Ninewells Hospital and Medical School,
Dundee, United Kingdom, 3Breast
Research Pathology, Research Oncology, King's College
London and Guy's Hospital, London, United Kingdom
We have examined regions of breast tumours using
diffusion MRI and fitting to compartment models that
characterize diffusion in the vascular, extracellular
and intracellular spaces. These were compared with
monoexponential apparent diffusion coefficient (ADC),
intravoxel incoherent motion (IVIM) and tensor models.
In the tumour center, diffusion ADC and IVIM best
explained the data, while tumour rim was best
characterized by a 3-compartment model including
isotropic restricted diffusion for the intracellular
component. This was in agreement with the low
cellularity in the tumour center and higher cellularity
in the rim observed on histology.
|
1083. |
Clinical Experience of
Acquiring Both High Spatial and High Temporal Resolution
Breast Dynamic Datasets Utilising a Differential Subsampling
with Cartesian Ordering k-space Acquisition Scheme
Martin D Pickles1, Dan W Rettmann2,
Kang Wang3, and Lindsay W Turnbull1
1Centre for Magnetic Resonance
Investigations, Hull York Medical School at University
of Hull, Hull, East Yorkshire, United Kingdom, 2Global
MR Applications and Workflow, GE Healthcare, Rochester,
MN, United States, 3Global
MR Applications and Workflow, GE Healthcare, Madison,
WI, United States
The aim of this work is to report initial clinical
experience of DIfferential Subsampling with Cartesian
Ordering (DISCO) dynamic breast examinations. In DISCO
k-space is divided into central and outer portions. The
outer portion of k-space is segmented into a number of
equal distributions regions via a pseudo-random
segmentation scheme. The central portion of k-space is
sampled every temporal frame while the outer edges are
subsampled sequentially. Temporal resolution is
minimised by implementing view-sharing. The results of
this work demonstrate that by utilising DISCO both high
spatial and high temporal resolution dynamic sequences
are possible.
|
1084. |
Modulated Flip Angle Single
Shot Fast Spin Echo: A Potential Means for Rapid T2W Breast
Imaging
Martin D Pickles1, Daniel Litwiller2,
Ersin Bayram3, Lloyd Estkowski4,
and Lindsay W Turnbull1
1Centre for Magnetic Resonance
Investigations, Hull York Medical School at University
of Hull, Hull, East Yorkshire, United Kingdom, 2Global
MR Applications and Workflow, GE Healthcare, Rochester,
MN, United States, 3Global
MR Applications and Workflow, GE Healthcare, Waukesha,
WI, United States, 4Global
MR Applications and Workflow, GE Healthcare, Menlo Park,
CA, United States
The aim of this work is to develop a T2W flip angle
modulation SSFSE protocol. In breast MRI, FSE images are
frequently utilised to acquire T2W images. SSFSE
represents an ultrafast sequence where efficiencies in
scan time could be made, however, SSFSE images are
associated with blurring. Refocusing flip angle
modulation has recently been utilised with SSFSE,
benefits include, faster acquisitions and improved
sharpness by limiting T2 decay. In this work T2W fat
nulled SSFSE images were acquired in 70 seconds and
provide radiologists with the same T2 information
available in longer FSE based sequences.
|
1085. |
T1 Mapping
of Human Breast Tissue using T1, T2 and
PD Weighted MRI Images at 3T
Anup Singh1, Prativa Sahoo2,
Vedant Kabra3, Indrajit Saha2,
Meenakshi Singhal3, and Rakesh Kumar Gupta3
1Center for Biomedical Engineering, Indian
Institute of Technology Delhi, New Delhi, Delhi, India, 2Philips
India Limited, Gurgaon, Haryana, India, 3Fortis
Memorial Research Institute, Gurgaon, Haryana, India
Objective of the current study was to obtain T1 mapping
of in vivo human breast using conventional 3D T1,
T2 and
PD weighted images and comparing the results of with and
without fat saturation. T1 is
an important parameter and its estimation is usually
required during quantitative analysis, particularly
during DCE-MRI data analysis. This simple approach,
based upon conventionally acquired T1, T2 and
PD weighted images, provided absolute quantitation of T1 in
in vivo breast tissue. In the current study, we have
shown that three data point (PD, T2 and
T1 W)
based approach for T1 estimation
works well for both with and without fat saturation.
|
1086. |
Automatic segmentation of
breast images using clustering and dynamic programming
José Angel Rosado-Toro1, Tomoe Barr2,
Marilyn T Marron3, Jean-Phillipe Galons4,
Patricia Thompson3, Alison Stopeck3,
Jeffrey Joel Rodríguez5, and María I Altbach4
1Electrical and Computer Engineering,
University of Arizona, Tucson, Arizona, United States, 2Biomedical
Engineering, University of Arizona, Tucson, AZ, United
States, 3Arizona
Cancer Center, University of Arizona, Tucson, Arizona,
United States, 4Medical
Imaging, University of Arizona, Tucson, Arizona, United
States, 5Electrical
and Computer Engineering, University of Arizona, Tucson,
Arizon, United States
A fully automated breast segmentation algorithm has been
developed to segment the breast anatomy using various
types of imaging pulse sequences. The segmentation first
finds the chest and breast pixels using a clustering
technique. Next it removes the chest pixels using a
dynamic programming technique on the vertical gradient.
Then it removes the skin pixels using a thinning
algorithm and finally it splits the two breasts using a
morphological technique. The performance of the
algorithm is evaluated on 202 breast imaging slices
using manually traced breast outlines as reference.
|
1087. |
Correlation of 3D MR-Based
Percent Breast Density with Apparent Diffusion Coefficient
of the Breast Fibroglandular Tissue
Jeon-Hor Chen1,2, Hon J Yu1, Yifan
Li1, Yoon Jung Choi3, Po Yun Huang4,
and Min-Ying Su1
1Center for Functional Onco-Imaging,
University of California, Irvine, CA, United States, 2Department
of Radiology, Eda Hospital and I-Shou University,
Kaohsiung, Taiwan, 3Department
of Radiology, Kangbuk Samsung Hospital, Seoul, Korea, 4Department
of Medical Imaging, China Medical University, Taichung,
Taiwan
This study investigated the association of 3D MR-based
breast density with apparent diffusion coefficient (ADC)
acquired from the fibroglandular tissue of the breast.
MR images from the contralateral normal breast of 38
women diagnosed with unilateral breast cancer were
retrospectively analyzed. The results from our study
noted a positive correlation of ADC values with
MR-measured percent breast density. This study proved
that women with higher breast density had higher stromal
matrix, which can be assessed using ADC.
|
1088. |
A Comparison of Breast
Tissue T1 Mapping Using Conventional Multi-flip Angle and
2-point Dixon Techniques
Reem Bedair1, Mary McLean2, Andrew
Patterson3, Roie Manavaki1, John
Griffiths2, Fiona Gilbert1, and
Martin Graves3
1University of Cambridge, Department of
Radiology, Cambridge, Cambridgeshire, United Kingdom, 2Cancer
Research UK Cambridge Research Institute, Cambridge,
Cambridgeshire, United Kingdom, 3Department
of Radiology, Cambridge University Hospitals NHS
Foundation Trust, Cambridge, Cambridgeshire, United
Kingdom
T10 mapping acquisitions of quantitative DCE-MRI is
generally performed without fat suppression. Recent
studies have used 2-point Dixon (2PD) reconstruction as
a time-effective method for obtaining robust water-only
images. This work compares the pre-contrast T10
relaxation times obtained using a conventional non-fat
suppressed multiple flip angle technique with a
fat-suppressed 2PD method in a cohort of patients with
locally advanced breast cancer at 3.0T. Our results show
an increase in the T1 measurement of fibroglandular
tissue on fat suppression. However, the mean T10 values
in tumours decrease. Our study demonstrates the
feasibility of rapid fat-suppression techniques for
quantitative DCE-MRI analysis.
|
1089. |
Optimisation of b-value
Distribution for Intravoxel Incoherent Motion (IVIM) Imaging
of Breast Cancer with Clinical Results
Nina L. Purvis1, Peter Gibbs2,
Martin D. Pickles2, and Lindsay W. Turnbull2
1Centre for MR Investigations, Hull York
Medical School, Hull, East Yorkshire, United Kingdom, 2Centre
for MR Investigations, University of Hull at HYMS, Hull,
East Yorkshire, United Kingdom
An investigation to find an optimised clinical b-value
protocol for IVIM imaging in breast lesions and its
application. B-value schemes were generated using
exponential and power-law spacing then the Cramer-Rao
Lower Bound of IVIM parameters was calculated. A b-value
scheme was chosen based on a figure of merit to balance
the relative errors of the parameters. Data was fitted
using mono and bi-exponential models. The RMSEs
indicated that the biexponential fit was better. The
results agree well with previously reported values. The
b-value scheme samples low b-values well, and allows an
acceptable amount of NEX for a short scan duration.
|
1090. |
Highly Accelerated DCE-MRI
Pharmacokinetic map Estimation through frequency domain
based Tofts model (HAET)
Nithin N Vajuvalli1, C K Dharmendra Kumar1,
Manoj G Bhosale1,2, and Sairam Geethanath1
1Medical Imaging Research Centre, Dayananda
Sagar College of Engineering, Bangalore, Karnataka,
India, 2Government
College of Engineering (COEP), Pune, Maharastra, India
DCE-MRI is used to assess tumor perfusion, microvascular
vessel wall permeability and extravascular–extracellular
volume fraction. Tofts Model (TM) in Time Domain (TD) is
computationally intensive for 3D data to obtain
Pharmacokinetic (PK) map using curve fitting. The
current work involves acceleration of curve fitting
process for the computation of PK map using Frequency
Domain (FD) based TM. Current work was demonstrated on
seven breast DCE datasets. Result show reduced
computational time for estimating PK map and reduced
NRMSE values in FD as compared to TD tofts model with
respect to randomly generated ground truth and in vivo
data.
|
1091. |
Design of a Spatially
Varying Saturation Pulse through Least-Squares
Tse Chiang Chen1 and
Philip Beatty1
1Medical Biophysics, University of Toronto,
Toronto, ON, Canada
Clean fat saturation in breast imaging remains
challenging. While spectral fat saturation is commonly
used for saturation, it is susceptible to field
inhomogeneity. The optimization of RF pulses with a
given trajectory in k-space may serve to bend spectral
selections in space, thereby covering field
inhomogeneity more effectively.
|
|
|
Monday 1 June 2015
Exhibition Hall |
10:45 - 12:45 |
|
|
|
1092. |
Monitoring cancer
treatment: quantitative MRI of tumor micro-structure and
metabolism with chemical exchange saturation transfer and
diffusion weighted MRI
Rozhin Yousefi1, Xiaoyong Huang2,
Stanley K. Liu2, and Greg J. Stanisz1,2
1Medical Biophysics, University of Toronto,
Toronto, Ontario, Canada, 2Sunnybrook
Research Institute, Toronto, Ontario, Canada
In recent years, the number of available treatment
modalities for cancer has increased significantly while
their effectiveness remains uncertain. Finding a
non-invasive imaging method to provide early assessment
of tumor response to therapy will significantly enhance
treatment outcome. Our proposed method is to apply
quantitative MRI (qMRI) to evaluate tumor
micro-structure and metabolism during treatment using
two MRI techniques: chemical exchange saturation
transfer (CEST) and diffusion weighted MRI (DW-MRI). In
vivo experimental results showed significant differences
in qMRI measurements of tumors including apparent
diffusion coefficient (ADC) and amine CEST peak, before
and after treatment.
|
1093. |
Determination of Tumor
Response to Hypoxia-Activated Prodrug TH-302 in Rat Glioma
Models
Ashley M Stokes1, Charles P Hart2,
and C. Chad Quarles1
1Institute of Imaging Science, Radiology and
Radiological Sciences, Vanderbilt University, Nashville,
TN, United States, 2Threshold
Pharmaceuticals, California, United States
Tumor hypoxia leads to increased tumor aggressiveness
and chemotherapeutic resistance, which has led to the
development of hypoxia-activated cytotoxic prodrugs,
such as TH-302. As tumor hypoxia is spatially
heterogeneous, and thus response to TH-302 is expected
to vary spatially, there is a need for imaging-based
measures of treatment response. Here, we determined
tumor response to TH-302 in two rat glioma models with
known differences in tumor hypoxia, and functional
diffusion mapping was used to quantify treatment-induced
changes in diffusion characteristics that could be
indicative of response to hypoxia activated drugs such
as TH-302.
|
1094. |
Multimodal Imaging of a
Mouse Model of Colorectal Carcinoma Metastasis in the Liver
Rajiv Ramasawmy1,2, Sean Peter Johnson1,2,
Thomas Anthony Roberts1, Daniel J Stuckey1,
Anna L David3, Rosamund Barbara Pedley2,
Mark Francis Lythgoe†1, Bernard Siow†1,
and Simon Walker-Samuel†1
1Centre for Advanced Biomedical Imaging,
University College London, London, Greater London,
United Kingdom, 2Cancer
Institute, University College London, London, Greater
London, United Kingdom, 3Institute
for Women's Health, University College London, London,
Greater London, United Kingdom
Orthotopic tumor models are thought to provide a more
clinically-representative model of disease than
traditional subcutaneous implantations, although their
siting often renders them more difficult to assess. In
this study, we compared 1T “benchtop” MRI and ultrasound
with our gold-standard techniques of bioluminescence
imaging (for cell detection) and 9.4T MRI (for tumour
volume assessment) in their ability to characterise the
development of liver metastases over four weeks. No
significant differences were observed in the measured
tumour doubling, showing that each of these techniques
can be used for characterising tumour growth in
deep-sited tumours, although each has characteristic
advantages and disadvantages.
|
1095. |
In Vivo Magnetic
Resonance Elastography in Pediatric Brain Tumor Models
Jessica K.R. Boult1, Jin Li1, Yann
Jamin1, Maria Vinci2,3, Sergey
Popov2,3, Karen Barker4, Zai Ahmad4,
Craig Cummings1, Suzanne A Eccles3,
Jeffrey C Bamber1, Ralph Sinkus5,
Louis Chesler4, Chris Jones2,3,
and Simon P Robinson1
1Division of Radiotherapy and Imaging, The
Institute of Cancer Research, London, United Kingdom, 2Division
of Molecular Pathology, The Institute of Cancer
Research, London, United Kingdom, 3CR-UK
Division of Cancer Therapeutics, The Institute of Cancer
Research, London, United Kingdom, 4Division
of Clinical Studies, The Institute of Cancer Research,
London, United Kingdom, 5Division
of Imaging Sciences & Biomedical Engineering, Kings
College London, London, United Kingdom
Refined imaging strategies that could improve diagnosis
and management of children with brain malignancies are
urgently required. MR elastography (MRE) has been used
to assess viscoelastic properties in the brain and brain
tumors clinically and preclinically. We evaluated
orthotopic D-212 MG pediatric glioblastoma xenografts
and GTML/Trp53KI/KI transgenic
medulloblastomas using MRE. Both tumor types
demonstrated reduced elasticity (Gd) and
viscosity (Gl) relative to the surrounding
brain. A bimodal distribution of Gd, not seen
previously, was observed in GTML/Trp53KI/KI tumors.
These data reinforce the potential of MRE for the
detection and differential diagnosis of pediatric brain
malignancies based on their mechanical properties.
|
1096. |
High-resolution MRI
analysis of breast cancer xenografts on the CAM @ 11.7T
Zhi Zuo1,2, Tatiana Syrovets3,
Felicitas Genze3, Alireza Abaei2,
Genshan Ma4, Thomas Simmet3, and
Volker Rasche1,2
1Internal Medicine II, University Hospital
Ulm, Ulm, Baden-Wurttemberg, Germany, 2Core
Facility Small Animal MRI, Medical Faculty, Ulm
University, Ulm, Baden-Wurttemberg, Germany,3Institute
of Pharmacology of Natural Products and Clinical
Pharmacology, Ulm University, Ulm, Baden-W¨¹rttemberg,
Germany, 4Department
of Cardiology, Zhongda Hospital, Medical School of
Southeast University, Nanjing, Jiangsu, China
High-resolution in ovo imaging is employed for
monitoring the growth of human breast cancer cells
grafted on the chorioallantonic membrane of chick
embryos. High-resolution imaging is achieved by using an
age-adopted precooling regime for immobilization of the
chick embryo. The proposed scheme is proven safe for the
chick embryo showing same survival rates as in a control
group. The high-resolution MRI enables quantification of
the tumor xenografts starting from d4 after grafting. A
good correlation between tumor volumes derived by MRI
and the weight of the tumor after extraction is shown.
|
1097. |
OKN-007 decreases tumor
necrosis and tumor cell proliferation and increases
apoptosis in a pre-clinical F98 rat glioma model
Rheal A. Towner1, Patricia Coutinho De Souza1,
Krithika Balasubramanian2, Charity Njoku1,
Nataliya Smith1, David L. Gillespie3,
Andrea Schwager4, Osama Abdullah5,
Kar-Ming Fung6, Debra Saunders1,
and Randy L. Jensen3
1Advanced Magnetic Resonance Center, Oklahoma
Medical Research Foundation, Oklahoma City, OK, United
States, 2Radiology
& Biomedical Imaging, University of California San
Francisco, CA, United States, 3Huntsman
Cancer Insitute, University of Utah Health Sciences
Center, UT, United States, 4Neurobiology
& Anatomy, University of Utah Health Sciences Center,
UT, United States, 5Small
Animal Core Facility, University of Utah, UT, United
States, 6Pathology,
University of Oklahoma Health Sciences Center, OK,
United States
Gliomas are the most lethal adult primary brain tumors
with a poor outcome. Here, we report the effects of
OKN-007 on the necrotic tumor core and non-necrotic
tumor parenchyma in the F98 rat glioma model assessed by
1H-MRSI, DWI, and histological analysis. Our results
that OKN-007 was able to reduce necrosis and tumor cell
proliferation. There was also an increase in apoptosis
following OKN-007 treatment which seemed to correlate
with spectroscopic lipid peak assessments. Our results
also indicated that both ADC and spectroscopic choline
measures are related to glioma cell density in the F98
rat glioma model.
|
1098. |
Oxidative ketone body
metabolism in rat brain tumors and the effect of the
ketogenic diet: evidence from in
vivo 1H-[13C]
MRS
Henk M. De Feyter1, Kevin L. Behar2,
Kevan L. Ip1, Fahmeed Hyder1,
Lester L. Drewes3, Robin A. de Graaf1,
and Douglas L. Rothman1
1Department of Diagnostic Radiology, Yale
University, New Haven, Connecticut, United States, 2Department
of Psychiatry, Yale University, CT, United States, 3Department
of Biomedical Sciences, University of Minnesota, MN,
United States
The ketogenic diet (KD; fat, protein, no carbohydrates)
creates a plasma nutrient profile similar to starvation:
increased levels of ketone bodies and reduced plasma
glucose levels, and has been proposed as metabolic
therapy for brain tumors. Brain tumor cells supposedly
cannot oxidize ketone bodies for energy metabolism in
contrast to normal brain cells, and therefore the KD
would result in starving of glucose-dependent brain
tumors. We investigated the capability of glioma cells
to oxidize beta-hydroxybutyrate, the most abundant
ketone body, using 13C
magnetic resonance spectroscopy. 9L and RG2 glioma cells
were studied both in
vitro and in
vivo while
administering [2,4-13C2]-
beta-hydroxybutyrate.
|
1099. |
MnMRI of Pancreatic Cancer
Lara Leoni1, Martin Andrews2,
Chin-Tu Chen3, Barry Lai4, and
Brian B. Roman5
1University of Chicago, Chicago, Il, United
States, 2University
of Chicago, IL, United States, 3Radiology,
University of Chicago, IL, United States, 4Argonne
National Laboratory, IL, United States, 5radiology,
university of chicago, Chicago, Illinois, United States
We have developed a MnMRI approach to detecting
pancreatic cancer in a murine model of human disease. We
utilized bioluminesence, MRI and XFM imaging to
determine the uptake of Mn by developing tumors. T1 maps
of the lesions indicated a decrease due to Mn
accumulation.
|
1100. |
Intravoxel Incoherent
Motion Diffusion Weighted Imaging(IVIM-DWI) on a mouse
xenografts model of human nasopharyngeal carcinoma CNE-2
cell line: A preliminary study on 3.0T MRI
Youping Xiao1, Yunbin Chen1,
Jianji Pan2, Ying Chen1, Yiqi Yao1,
Xiang Zheng1, Xiangyi Liu1, Dechun
Zheng1, and Weibo Chen3
1Radiology, Fujian Provincial Cancer
Hospital, Fuzhou, Fujian, China, 2Radiation
Oncology, Fujian Provincial Cancer Hospital, Fuzhou,
Fujian, China, 3Philips
Healthcare, Shanghai, China
The results of this present study shows that intravoxel
incoherent montion diffusion weighted imaging(IVIM-DWI)
derived parameters present a good producibility and
feasibility on xenografts of human nasopharyngeal
carcinoma(NPC) cell line CNE-2 which have a significant
higher D(pure diffusion coefficient) and a lower
f(fraction of perfusion) parameter. It is indicated that
IVIM-DWI would be valuable in helping evaluate the
micro-environment characteristic of diffusion and
perfusion in NPC's xenograft, especially during the
process of chemoradiotherapy.
|
1101. |
Mechanical characterization
of a mouse GL261 glioma model using MR elastography
Jing Guo1, Simon Bayerl2, Jürgen
Braun3, Peter Vajkoczy2, and
Ingolf Sack4
1Radiology, Charité - Universitätsmedizin
Berlin, Berlin, Berlin, Germany, 2Department
of Neurosurgery, Charité - Universitätsmedizin Berlin,
Berlin, Germany, 3Department
of Medical Informatics, Charité - Universitätsmedizin
Berlin, Berlin, Germany, 4Radiology,
Charité - Universitätsmedizin Berlin, Berlin, Germany
MR elastography (MRE) was performed to study the
viscoelasticity of glioblastoma (GB) in the GL261 mouse
model. We found that the magnitude of the complex shear
modulus |G*| of the tumor was significantly reduced
while the phase angle showed a large heterogeneity of
values compared to healthy brain tissue. Our results
corroborate clinical studies of MRE in GB and raise the
prospect of assessing tumor malignancy by tissue
mechanical constants.
|
1102. |
MR characterization of a
syngeneic orthotopic ovarian tumor model
Marie-France Penet1, Balaji Krishnamachary1,
Flonné Wildes1, Yelena Mironchik1,
Chien-Fu Hung2, TC Wu2, and Zaver
M Bhujwalla1
1JHU ICMIC Program, Division of Cancer
Imaging Research, The Russell H Morgan Department of
Radiology, The Johns Hopkins University School of
Medicine, Baltimore, MD, United States,2Department
of Pathology, The Johns Hopkins University School of
Medicine, Baltimore, MD, United States
Epithelial ovarian cancer remains the leading cause of
death from gynecologic malignancy among women in
developed countries. Identifying mechanisms that drive
the aggressiveness of ovarian cancers and its associated
pathologies, such as the formation of metastases and the
build-up of ascitic fluid, is urgently needed to provide
new targets in effective control and treatment.
Noninvasive magnetic resonance imaging (MRI) and
magnetic resonance spectroscopic imaging (MRSI) provide
opportunities to characterize the tumor microenvironment
and to assess its relationship with ascites and
metastases. We applied MRI and MRSI to better
characterize ascites formation in a syngeneic orthotopic
experimental model of ovarian cancer.
|
1103. |
MRI accurately identifies
early murine mammary cancers and reliably differentiates
between in
situ and
invasive cancer: Correlation of MRI with histology
Devkumar Mustafi1, Erica Markiewicz1,
Marta Zamora1, Xiaobing Fan1,
Jeffrey Mueller2, Suzanne D Conzen3,
and Gregory S Karczmar1
1Radiology, The University of Chicago,
Chicago, IL, United States, 2Pathology,
The University of Chicago, Chicago, IL, United States, 3Medicine,
Section of Hematology and Oncology, The University of
Chicago, Chicago, IL, United States
Precise MRI-histopathology correlation demonstrates that
MRI accurately identifies mammary cancer at various
stages of development in the widely used C3(1)SV40Tag
mouse model, and provides a tool for the development of
image-based markers that differentiate indolent from
aggressive cancer. 96% of in
situ and
100% of invasive cancers identified on in
vivo MRI
agreed with histology. Methods described here will allow
investigators to develop better MRI-based markers for
tumor progression, improve understanding of cancer
initiation and progression, evaluate response to therapy
in murine models of breast cancer, and provide valuable
insights regarding clinical management of patients with
early breast cancers.
|
1104. |
Validation of anti-VEGF
Therapy in a Radiation Necrosis Mouse Model
Carlos J Perez-Torres1, Liya Yuan2,
Robert E Schmidt3, Keith M Rich2,
Robert E Drzymala4, Joseph JH Ackerman1,5,
and Joel R Garbow1
1Radiology, Washington University, Saint
Louis, MO, United States, 2Neurosurgey,
Washington University, Saint Louis, MO, United States, 3Neuropathology,
Washington University, Saint Louis, MO, United States, 4Radiation
Oncology, Washington University, Saint Louis, MO, United
States, 5Chemistry,
Washington University, Saint Louis, MO, United States
The use of anti-VEGF antibodies represents a new
treatment approach for radiation necrosis. We present a
timeline of VEGF expression and test the effectiveness
and specificity of anti-VEGF antibody treatment in our
mouse model of radiation necrosis. While the anti-VEGF
antibody treatment has an effect on the extent of
injury, it does not reduce VEGF expression. The
persistence of VEGF could lead to the recurrence of
injury once treatment is stopped.
|
1105. |
Correlation of Quantitative
MRI-derived Tumor Characteristics with Histology in Breast
Cancer Murine Models
Anna G Sorace1,2, Stephanie L Barnes1,2,
Jennifer G Whisenant1,2, Mary E Loveless1,
and Thomas E Yankeelov1,2
1Radiology and Radiological Sciences,
Vanderbilt University, Nashville, Tennessee, United
States, 2Vanderbilt
University Institute of Imaging Science, Vanderbilt
University, Nashville, Tennessee, United States
This study evaluated the relationship between the
apparent diffusion coefficient (ADC), the extravascular
extracellular volume fraction (ve),
and quantitative histology measurements using two
preclinical breast cancer models, BT474 and MDA-MB-231.
Quantitative imaging biomarkers can reveal treatment
response, however better validation of the techniques
needs to occur prior to translation. While ADC reveals
significant correlations with the extracellular space in
both preclinical models, this data adds to the growing
body of literature which suggests that ve is
not a reliable biomarker of extracellular space.
|
1106. |
Importance of
characterizing water content in quantifying metabolites in
pancreatic cancer and normal pancreas
Marie-France Penet1, Balaji Krishnamachary1,
Tariq Shah1, Yelena Mironchik1,
Anirban Maitra2, and Zaver M Bhujwalla1
1JHU ICMIC Program, Division of Cancer
Imaging Research, The Russell H Morgan Department of
Radiology, The Johns Hopkins University School of
Medicine, Baltimore, MD, United States,2MD
Anderson Cancer Center, The University of Texas, TX,
United States
There is a critical need for identifying and developing
new noninvasive biomarkers and therapeutic targets in
pancreatic cancer. We recently observed aberrant choline
metabolism in subcutaneous and orthotopically implanted
human pancreatic cancer xenografts using 1H MR
spectroscopic imaging. However, high-resolution proton
spectra of tumors and pancreatic tissue extracts
normalized to the water signal assuming similar water
content did not reflect the significantly increased
total choline observed in vivo. Our purpose here was to
determine the differences in water content between
pancreatic tumors and the pancreas to accurately
quantify differences in metabolism when using the water
signal for normalization.
|
1107. |
Evaluation of nanoparticle
accumulation and treatment efficacy for a combined
heavy-ion-beam irradiation and drug-delivery tumor therapy
Daisuke Kokuryo1, Eiji Yuba2,
Kenji Kono2, Tsuneo Saga1, and
Ichio Aoki1
1Molecular Imaging Center, National Institute
of Radiological Sciences, Chiba, Chiba, Japan, 2Graduate
School of Engineering, Osaka Prefecture University,
Sakai, Osaka, Japan
A combination treatment using carbon-ion-beam
irradiation and multimodal thermo-sensitive
polymer-modified liposomes (MTPLs) containing contrast
agents and anti-cancer drug was developed. The
accumulation and treatment effects of the MTPLs were
evaluated in in
vivo experiments
on subcutaneously xenografted tumor model mice. MTPLs
accumulated in the tumor region regardless of the
influence of carbon-beam irradiation and the efficacy of
the combination treatment increased after
heat-triggering of drug release. It was concluded that
the proposed strategy provided an effective anti-cancer
treatment.
|
1108. |
NMR based
pharmacometabolomics for evaluating the drug response of
polyherbal formulations
Gaurav Sharma1, Somenath Ghatak1,
Arun Kumar Verma2, Thirumurthy Velpandian3,
and Rama Jayasundar1
1NMR, All India Institute of Medical
Sciences, New Delhi, Delhi, India, 2Biotechnology,
All India Institute of Medical Sciences, New Delhi,
Delhi, India, 3Pharmacology,
All India Institute of Medical Sciences, New Delhi,
Delhi, India
Although single molecule drugs remain the focus of drug
development, polyherbal formulations are evoking
interest due to their synergistic activity, low toxicity
and multitargeting potential. The objective of this
study is to evaluate the pharmacometabolic response of
chick Chorio-Allantoic Membrane (CAM) to polyherbal
formulations using high resolution NMR and also assess
their antiangiogenic potential using CAM assay. The
significant inhibition of neovascularization by the
formulations comparable to that of the synthetic
chemotherapy drug thalidomide, was reflected in both the
CAM assay and NMR spectral data. In the latter, it
showed as significant reduction in choline, pyruvate,
and lactate peaks.
|
|
|
Monday 1 June 2015
Exhibition Hall |
10:45 - 12:45 |
|
|
|
1109.
|
Relaxation along fictitious
field, diffusion weighted imaging, and T2 mapping
of prostate cancer: correlation of quantitative values with
Gleason score
Ivan Jambor1, Marko Pesola1, Harri
Merisaari2, Pekka Taimen3, Peter J
Boström4, Timo Liimatainen5, and
Hannu J Aronen1
1Department of Diagnostic Radiology,
University of Turku, Turku, Finland, 2Turku
PET Centre, University of Turku, Turku, Finland, 3Department
of Pathology, Turku University Hospital, Turku, Finland, 4Department
of Urology, Turku University Hospital, Turku, Finland, 5Department
of Biotechnology and Molecular Medicine, A.I. Virtanen
Institute for Molecular Sciences, University of Eastern
Finland, Kuopio, Finland
Fifth-one patients with histologically confirmed PCa
underwent 3T MRI consisting of relaxation along
fictitious field (RAFF), diffusion weighted imaging (DWI),
b valeus of 0, 100, 300, and 500 s/mm2, and T2 mapping.
Using whole mount prostatectomy sections and anatomical
T2-weighted images as reference, one ROI was
placed in the center of PCa area and the same sized ROI
in the peripheral zone, and central gland not containing
PCa. High spearman correlation coefficient value of
-0.68 was found for correlation of RAFF relaxation
values with Gleason score groups, outperforming DWI (ADCm)
and T2 mapping.
|
1110. |
Repairing the Brain with
Physical Exercise: Insights from Cortical Thickness Analysis
of An Exercise Trial in Pediatric Brain Tumor Survivors
Kamila U Szulc1, Ade Oyefiade2,
Lily Riggs1,2, Eric Bouffet3,4,
Suzanne Laughlin5, Brian W Timmons6,
Jason P Lerch7, Cynthia B de Medeiros2,
Jovanka Skocic1, and Donald J Mabbott1,2
1Neurosciences and Mental Health, Hospital
for Sick Children, Toronto, Ontario, Canada, 2Department
of Psychology, Hospital for Sick Children, Toronto,
Ontario, Canada, 3Division
of Haematology/Oncology, Hospital for Sick Children,
Toronto, Ontario, Canada, 4Department
of Pediatrics, Hospital for Sick Children, Toronto,
Ontario, Canada, 5Diagnostic
Imaging, Hospital for Sick Children, Toronto, Ontario,
Canada, 6Department
of Pediatrics, McMaster University, Hamilton, Ontario,
Canada, 7Mouse
Imaging Centre, Hospital for Sick Children, Toronto,
Ontario, Canada
Cranial radiation is a standard form of treatment for
malignant brain tumors. While radiation increases
survival rates, it also leads to long-term cognitive
impairments and neurodegeneration. Unfortunately, there
is no cure or standard of care for these
treatment-related effects. Recently, there have been a
growing number of studies showing the benefits of
physical activity for the brains of healthy children,
but its potential as a rehabilitative technique remains
unknown. We conducted a 12-week program to examine
whether aerobic exercise can stimulate brain repair
processes in pediatric brain tumor survivors treated
with cranial radiation. Specifically, we examined the
effects of exercise on cortical thickness.
|
1111. |
Manganese-enhanced MRI of
minimally gadolinium-enhancing breast tumors
Hai-Ling Margaret Cheng1,2, Tameshwar Ganesh2,
Reza Bayat Mokhtari3, Mosa Alhamami2,
and Herman Yeger3
1Institute of Biomaterials & Biomedical
Engineering, University of Toronto, Toronto, Ontario,
Canada, 2Physiology
& Experimental Medicine, Hospital for Sick Children,
Toronto, Ontario, Canada, 3Developmental
& Stem Cell Biology, Hospital for Sick Children,
Toronto, Ontario, Canada
Contrast-enhanced MRI is as essential component of
oncological imaging. However, tumors with low
vascularity, such as some low-grade gliomas, or ones
that become non-enhancing following antiangiogenic
treatment, may not enhance appreciably relative to
surrounding normal tissue. In this study, we investigate
the potential of manganese (Mn)-enhanced MRI for
sensitive detection of tumors that demonstrate little
enhancement on Gd-DTPA. Results in tumor-bearing rats
demonstrated MnCl2 administration achieved greater and
more uniform enhancement throughout the tumor mass (i.e.
was not restricted to tumor periphery). Histology
confirmed very low vascularity, and necrotic areas were
well delineated only on Mn-enhanced MRI.
|
|
|
|
Monday 1 June 2015
Exhibition Hall |
10:45 - 12:45 |
|
|
|
1112. |
Investigating pH and other
effects of a proton pump inhibitor (PPI) in cancer models
with 31P
magnetic resonance
Gopal Varma1, Xiaoen Wang1, Han
Xie2, Gerburg Wulf3, Pankaj Seth2,
David C Alsop1, Aaron K Grant1,
and Vikas P Sukhatme2
1Radiology, Division of MR Research, Beth
Israel Deaconess Medical Center, Harvard Medical School,
Boston, Massachusetts, United States, 2Department
of Medicine, Beth Israel Deaconess Medical Center,
Harvard Medical School, Boston, Massachusetts, United
States, 3Division
of Hematology and Oncology, Department of Medicine, Beth
Israel Deaconess Medical Center, Harvard Medical School,
Boston, Massachusetts, United States
Proton pump inhibitors (PPIs) hold potential for
treatment of cancer treatment by disrupting the
transport of excess hydrogen ions out of cancer cells
that maintains a normal intracellular pH and forms an
acidic extracellular environment. The effect of a PPI
combination on preclinical models of breast and
non-small cell lung cancer was studied using
slice-selective 31P spectroscopy through the tumor up to
40 minutes post drug injection. Intracellular pH
decreased significantly following treatment. In
addition, a more significant increase in Pi/γATP ratio
from pre- to post-injection periods was observed.
|
1113. |
19F MRSI of capecitabine in
the liver using broadband TxRx antennas and dual-frequency
excitation pulses at 7T
Jetse van Gorp1, Peter Seevinck1,
Anna Andreychenko2, Alexander Raaijmakers2,
Peter Luijten3, Miriam Koopman4,
Vincent Boer3, and Dennis Klomp3
1Image Sciences Institute, University Medical
Center Utrecht, Utrecht, Utrecht, Netherlands, 2Department
of Radiotherapy, University Medical Center Utrecht,
Utrecht, Utrecht, Netherlands,3Department of
Radiology, University Medical Center Utrecht, Utrecht,
Utrecht, Netherlands, 4Department
of Medical Oncology, University Medical Center Utrecht,
Utrecht, Utrecht, Netherlands
In this work, the feasibility to detect orally
administered chemotherapy (capecitabine) in the liver
was investigated at a clinical 7T MR system. The system
was equipped with a broadband radiative antenna to
acquire both 1H and 19F signal, and dual-frequency
excitation pulses were implemented to overcome
excitation issues. Pulse acquire and 3D spectroscopic
imaging 19F spectra were successfully acquired in two
patients at 1 and 10 hours after drug intake. The
results show that it is feasible to monitor chemotherapy
metabolism at 7T in the human body.
|
1114. |
Mean-Shift Clustering for
Assessing Response Heterogeneity in Bone Metastases
Sarah Ann Mason1, Nina Tunariu1,
Dow-Mu Koh1, David J Collins1,
Martin O Leach1, and Matthew D Blackledge1
1Institute of Cancer Research and Royal
Marsden Hospital, Sutton, Surrey, United Kingdom
No single MR sequence can fully represent the underlying
biology in bone metastases, which necessitates that
clinicians employ complementary image data for disease
diagnoses, response assessments, and treatment
decisions. The sheer volume of data can make image
interpretation complex and overwhelming. We introduce a
method for consolidating information by identifying like
regions in the bone (e.g. active disease) based on a
mean-shift analysis of fat fraction (FF), apparent
diffusion coefficient (ADC), and spatial location. This
non-parametric method provides superb data
visualization, makes no assumptions about the underlying
data distributions, and can track changes in the region
of interest over time.
|
1115. |
cPLA2 inhibition affects
the relationship between vascular function and structure in
a patient-derived breast cancer model: a correlation study
of DCE-MRI vs. micro-CT
Eugene Kim1, Astrid Jullumstrø Feuerherm2,3,
Berit Johansen2,3, Olav Engebraaten4,
Gunhild Mari Mælandsmo4, Tone Frost Bathen1,
and Siver Andreas Moestue1
1MR Cancer Group, Department of Circulation
and Medical Imaging, Norwegian University of Science and
Technology, Trondheim, Norway, 2Department
of Biology, Norwegian University of Science and
Technology, Trondheim, Norway, 3Avexxin
AS, Trondheim, Norway, 4Department
of Tumor Biology, Institute for Cancer Research, Oslo
University Hospital, Oslo, Norway
DCE-MRI and ex vivo micro-CT angiography were used to
investigate the relationship between tumor vascular
function and structure, and the effect of a cytosolic
phospholipase A2 (cPLA2) inhibitor (AVX235, Avexxin AS)
on this relationship, in a patient-derived breast cancer
model. In control tumors (n=7), there were good
correlations between Ktrans and vascular surface area
(SA) (r=0.67) and between vp and SA (r=0.7). In
AVX235-treated tumors (n=9), these correlations were
weaker (r=0.25 and 0.33, respectively). This suggests
that cPLA2 inhibition modulated the link between
vascular structure and function and had a spatially
heterogeneous effect on blood flow and/or vessel
permeability.
|
1116. |
Assessing the utility of
Oxygen-Enhanced Magnetic Resonance Imaging (OE-MRI) to
predict radiation response of rat prostate Tumors
Derek A White1,2, Zhang Zhang3,
Heling Zhou1, Debu Saha3, Peter
Peschke4, Zhongwei Zhang1, and
Ralph P Mason5
1Radiology, University of Texas Southwestern,
Dallas, Texas, United States, 2Bioengineering,
University of Texas at Arlington, Texas, United States, 3Radiation
Oncology, University of Texas Southwestern, Dallas,
Texas, United States, 4Clinical
Cooperation Unit Molecular Radiooncology, German Cancer
Center, Heidelberg, Germany, 5Radiology,
University of Texas Southwestern, Dallas, TX, United
States
Non-invasive prognostic biomarkers promise new insights
into tumor pathophysiology potentially allowing therapy
to be optimized. Notably hypoxia influences radiation
responses and Oxygen sensitive MRI (BOLD and TOLD) are
sensitive to tissue oxygenation. This study further
explores relationships between R1, R2* of rat prostate
tumors with respect to oxygen breathing challenge and
the tumor growth delay induced by a split dose radiation
regimen. Oxygen breathing was found to enhance tumor
growth delay and correlations were found with R1 and R2*
assessed before the first dose of radiation.
|
1117. |
Quantitative Analysis of
Multi-parametric FLT-PET/MRI in Evaluating Early Treatment
Response in Renal Cell Carcinoma
Jacob Antunes1, Satish Viswanath1,
Mirabela Rusu1, Laia Valls2,
Norbert Avril2, Christopher Hoimes2,
and Anant Madabhushi1
1Center for Computational Imaging and
Personalized Diagnostics, Case Western Reserve
University, Cleveland, OH, United States, 2University
Hospitals Case Medical Center, Cleveland, OH, United
States
We present a framework for quantitatively evaluating
early treatment response of renal cell carcinoma (RCC).
A single RCC patient was imaged using an integrated
T2W/PET and DWI sequence before and during cytostatic
drug treatment. Sequences within an acquisition protocol
were spatially aligned and co-registered between
acquisition time points. SUV, ADC-map, and T2W textural
feature intensities were extracted on a per-voxel basis.
A weighted difference map combination of multiple
PET/MRI parameters was computed to optimize for expected
changes within annotated RCC and normal tissue regions.
The integrated multi-parametric PET/MRI map demonstrated
high specificity in identifying early treatment response
in metastatic RCC.
|
1118. |
Early detection of
treatment-induced apoptosis in tumors using temporal
diffusion spectroscopy MRI
Xiaoyu Jiang1, Hua Li1, Ping Zhao1,
H. Charles Manning1, Junzhong Xu1,
and John C. Gore1
1Institute of Imaging Science, vanderbilt
university, nashville, Tennessee, United States
The restoration of apoptosis in cancer cells is a
critical strategy in the development of novel
anti-cancer therapies. In vivo detection of apoptosis
may provide early assessment of therapeutic response,
however, none of the current imaging methods have proven
robustly successful in clinics. Apoptosis at early
stages is associated with significant microstructural
variations, including nuclear fragmentation, cytosolic
condensation, and cellular shrinkage. Here we show that
temporal diffusion spectroscopy, a technique that is
capable of characterizing microstructural variations
across intracellular to cellular length scales, can
provide an early, non-invasive and specific detection of
the microstructural variations associated with
treatment-induced apoptosis.
|
|
|
Monday 1 June 2015
Exhibition Hall |
10:45 - 12:45 |
|
|
|
1119. |
Highly accelerated DCE-MRI
using Region of Interest Compressed Sensing
Amaresha Shridhar Konar1, Nithin N Vajuvalli1,
Rashmi R Rao1, Divya Jain1,
Dharmendra CK Kumar1, and Sairam Geethanath1
1Medical Imaging Research Center, Dayananda
Sagar College of Engineering, Bangalore, Karnataka,
India
Current work demonstrates a technique, Region Of
Interest Compressed Sensing (ROICS) on DCE-MRI data
where ROI was selected around the tumor, restricting the
reconstruction to the ROI. Compressed Sensing (CS) and
ROICS methods were applied on seven breast DCE-MRI data
sets at chosen acceleration factors from 2x to 20x. The
reconstructed images were used to obtain quantitative
Pharmacokinetic maps (PK) and the error in
reconstruction was quantified by Normalized Root Mean
Square Error (NRMSE) value. A significant increase in
NRMSE value and artifacts in PK maps are observed from
5x acceleration onwards for CS as compared to ROICS.
|
1120. |
Perfusion correlated
heterogeneity in NSCLC patient tumor glucose metabolism
Christopher Hensley1, Eunsook Jin2,3,
Naama Lev-Cohain4, Qing Yuan4,
Kemp Kernstine5, Craig Malloy6,7,
Robert Lenkinski6,7, and Ralph Deberardinis8,9
1Children's Research Institute, University of
Texas Southwetern Medical Center, Dallas, Texas, United
States, 2Advanced
Imaging Research Center, University of Texas Southwetern
Medical Center, Texas, United States, 3Internal
Medicine, University of Texas Southwetern Medical
Center, Texas, United States, 4Radiology,
University of Texas Southwetern Medical Center, Texas,
United States, 5Cardiovascular
and Thoracic Surgery, University of Texas Southwetern
Medical Center, Texas, United States, 6Advanced
Imaging Research Center, University of Texas Southwetern
Medical Center at Dallas, Texas, United States, 7Radiology,
University of Texas Southwetern Medical Center at
Dallas, Texas, United States, 8Children's
Research Institute, University of Texas Southwetern
Medical Center at Dallas, Texas, United States, 9Pediatrics,
University of Texas Southwetern Medical Center at
Dallas, Texas, United States
Significant inter- and intratumoral heterogeneity in in
vivo glucose metabolism as assayed by [U-13C] glucose
infusions exist in non-small cell lung cancer (NSCLC)
patient primary tumors. We believe
microenvironment-based advanced imaging methods can be
used as pre-operative markers for intraoperative tumor
fragment sampling to begin to study the magnitude of
non-cell autonomous regulation of lung tumor metabolism.
We demonstrate this proof of concept with DCE-MRI to
assay the effects of heterogeneity in tumoral perfusion
on both oxidative and non-oxidative NSCLC patient tumor
glucose metabolism.
|
1121. |
Monitoring quantitative
tumor blood volume in mouse brain under Bevacizumab by the
RSST1-MRI method.
Michel Sarraf1,2, Flavien Caraguel1,
François Berger1, Boudewijn Van Der Sanden1,
and Hana Lahrech1
1CEA-CLINATEC, Grenoble, Isère, Rhône-Alpes,
France, 2Saint
Joseph University, Beyrouth, Lebanon
Blood volume fraction (BVf) and vessel permeability have
been shown to indicate anti-angiogenic therapy response
at an early stage (before changes in tumor size appear).
This study demonstrates the sensitivity of the RSST1-MRI
method to quantify BVf, to detect the vasculature
changes in U87 human glioblastoma cell (in mouse brain)
at an early stage, after treatment with Bevacizumab,
which is injected intravenously at a dose of 10 mg/kg
(Student t-test: Pvalue <0.05). RSST1 is suitable to
assess the effect of new anti-angiogenic therapies, and
help physicians to take early decisions to stop,
continue or change therapy strategies during treatment.
|
|
|
Monday 1 June 2015
Exhibition Hall |
10:45 - 12:45 |
|
|
|
1122. |
13C NMR studies of lymphoma
and melanoma cells in the perfusion bioreactor and in vivo
xenografts for flux calculation
Seung-Cheol Lee1, Jeffrey Roman1,
Kavindra Nath1, David Nelson1,
Kevin Muriuki1, Alexander Shestov1,
and Jerry Glickson1
1Department of Radiology, University of
Pennsylvania, Philadelphia, PA, United States
Time course 13C NMR study was performed in the perfused
lymphoma and melanoma cells as well as in vivo
xenografts for detailed metabolic flux calculation. mTOR
signaling inhibitor rapamycin was administered to
lymphoma cells and xenografts. Well resolved time course
13C NMR spectra were obtained from both perfused cells
and in vivo tumors. mTOR signaling inhibition decreased
fluxes to lactate, glutamate as well as glycogen.
Melanoma xenografts exhibited higher TCA cycle flux than
lymphoma xenografts. Quantitative flux calculation is
under process.
|
1123. |
13C MRS/Bioreactor
Technique to Study Melanoma: Quantifying Glutaminolysis and
de novo Lipogenesis
Alexander A. Shestov1, Anthony Mancuso2,
Pierre Gilles Henry3, Dennis B. Leeper4,
and Jerry David Glickson5
1Radiology, University of Pennsylvania,
Philadelphia, PA, United States, 2Radiology,
University of Pennsylvania, PA, United States, 3University
of Minnesota, MN, United States, 4Radiation
Oncology, Thomas Jefferson University, PA, United
States, 5Radiology,
Univesity of Pennsylvania, PA, United States
The bioreactor techniques combined with 13C MRS are an
important tool to study cancer cell metabolism. Modeling
of intracellular MRS isotopomer data obtained during
perfusion with 13C labeled substrates allows
quantitative determination of transport and metabolic
parameters in vivo/in situ. In this work, we apply a
novel 13C metabolic flux analysis technique to elucidate
cancer metabolism bionetwork and calculate fluxes
through important cancer metabolic pathways.
|
1124. |
Noninvasive Image-Based
Quantification of 18F-fluoromisonidazole (FMISO) Uptake
using PET/MRI
Dragana Savic1, Youngho Seo1,
Randall Hawkins1, Soonmee Cha1,
Miguel Pampaloni1, Sharmila Majumdar1,
and Ramon Barajas1
1Radiology and Biomedical Imaging, University
of California, San Francisco (UCSF), San Francisco,
California, United States
We present a non-invasive image-based quantification
method for estimating the activity in patients using an
investigational simultaneous TOF PET/MRI scanner.
Patients were injected with 18F-fluormisonidazole, and
the average activity was calculated from the whole blood
samples, and compared to the activity from the PET/MRI
scanner. The average MRI blood-to-blood ratios were 1.16
and 1.18 respectively for the carotid arteries and the
jugular veins. These results suggest that we can do
image-derived blood activity concentration calculation
reproducibility, and potentially avoid invasive blood
sample procedures, by the use of our image derived
quantification method using a hybrid simultaneous TOF
PET/MRI scanner.
|
1125. |
Investigation of
Prostate Cancer Metabolomics with Prostate Biopsy Cores
Emily Decelle1, Taylor Fuss1,
Shulin Wu1, Adam Feldman2, Douglas
Dahl2, Aria Olumi2, W Scott
McDougal2, Chin-Lee Wu1, and Leo L
Cheng3
1Pathology, Massachusetts General Hospital,
Boston, MA, United States, 2Urology,
Massachusetts General Hospital, Boston, MA, United
States, 3Pathology
and Radiology, Massachusetts General Hospital, Boston,
MA, United States
Prostate cancer (PCa) is the second leading cause of
cancer death and the most frequently diagnosed
malignancy in men worldwide. Previous observations show
that PCa metabolic information can delocalize from PCa
glands and into histologically-benign tissue creating
“field effects” resulting in “metabolomic lesions” that
are larger than histology lesions. In this study, we
evaluate these effects with location defined prostate
biopsy samples from patients suspected of harboring PCa
using high-resolution magic angle spinning MR
spectroscopy at 14.1T with constructions of training and
testing cohorts created through quantitative
histopathology of the biopsy cores.
|
1126. |
Differences in phospholipid
and lipid metabolism between cancer cells in culture and in
solid tumors
Noriko Mori1, Flonné Wildes1,
Tomoyo Takagi1, Kristine Glunde1,2,
and Zaver M. Bhujwalla1,2
1The Russell H. Morgan Department of
Radiology and Radiological Science, The Johns Hopkins
University School of Medicine, Baltimore, MD, United
States, 2The
Sidney Kimmel Comprehensive Cancer Center, The Johns
Hopkins University School of Medicine, MD, United States
Abnormal phospholipid and lipid metabolism are
characteristic features of cancer. Cancer cells in
culture do not completely mirror observations made in
vivo because of the strong influence of the tumor
microenvironment. In our ongoing studies we are
comparing phosphocholine/glycerophosphocholine and lipid
levels in prostate and breast cancer cells and tumors
using 1H MR spectroscopy, to further understand
metabolic processes. We have compared protein levels of
the related enzymes to the metabolisms in these cells
and tumors. Significantly different protein levels
observed between cells in culture and tumors demonstrate
the importance of the tumor microenvironment in
phospholipid and lipid metabolism.
|
1127. |
Glutamate dehydrogenase
inhibition reduces glutamine conversion into 2HG in
IDH1-mutated cancer cells as detected by 13C
MRS
Tom Peeters1, Vincent Breukels1,
Corina van den Heuvel2, Anna Navis2,
Sanne van Lith2, Jack van Asten1,
Remco Molenaar3, William Leenders2,
and Arend Heerschap1
1Department of Radiology and Nuclear
Medicine, Radboudumc, Nijmegen, Netherlands, 2Department
of Pathology, Radboudumc, Nijmegen, Netherlands, 3Department
of Cell Biology and Histology, Academic Medical Center,
Amsterdam, Netherlands
Mutational changes in cytosolic isocitrate dehydrogenase
1 (IDH1) result in production of NADP+ and
the oncometabolite D-2HG at the expense of αKG and
NADPH. Replenishment of αKG from glutamine is one of the
compensatory anaplerotic mechanisms that allow tumor
cells to survive the induced metabolic stress. We
investigated the effect of epigallocatechin gallate
(EGCG), a known inhibitor of glutamate dehydrogenase 1
(GDH1), on the fate of 13C-glutamine
using 13C
MRS in IDH1wt/R132H and
IDH1wt/wt cancer
cells. EGCG significantly inhibits proliferation of IDH1wt/R132H cells.
EGCG also prohibits the conversion of glutamine into
D-2HG and changes intracellular glutamate and glutamine
pool sizes.
|
1128.
|
In vivo high resolution
multifrequency MR elastography of neuro tumors compared to
single cell mechanical properties
Ingolf Sack1, Anatol Fritsch2,
Steve Pawlizak2, Martin Reiss-Zimmermann3,
Karl-Titus Hoffmann3, Felix Arlt4,
Wolf Müller5, Jing Guo1, Jürgen
Braun6, and Josef Käs2
1Radiology, Charité - Universitätsmedizin
Berlin, Berlin, Berlin, Germany, 2Physics
and Earth Sciences, University of Leipzig, Saxony,
Germany, 3Department
of Neuroradiology, University Hospital, University of
Leipzig, Saxony, Germany, 4Department
of Neurosurgery, University Hospital, University of
Leipzig, Saxony, Germany, 5Department
of Neuropathology, University Hospital, University of
Leipzig, Saxony, Germany, 6Department
of Medical Informatics, Charité - Universitätsmedizin
Berlin, Berlin, Germany
This study aims to bridge the gap between micro and
macro scales of viscoelastic tissue properties in
tumors. High resolution MRE was applied within clinical
routine exams for measuring in-vivo viscoelastic
properties of 7 cerebral tumors of different entity.
Single cell viscoelastic properties of the same tumors
were measured after surgery by the optical stretcher. We
observed a significant correlation between in-vivo MRE
and single cell elasticity with marked softening in
high-WHO grade tumors. Thus, cellular mechanics is an
important marker for in-vivo tissue viscoelasticity by
which tumors can be staged in the future using MRE.
|
1129. |
Amine as a novel biomarker
for differentiating malignancy of breast cancer cells
Xiao-Yong Zhang1, Jingping Xie1,
Hua Li1, Junzhong Xu1, John C.
Gore1, and Zhongliang Zu1
1Institute of Imaging Science, Vanderbilt
University, Nashville, TN, United States
To differentiate the malignancy of breast cancer cells
is vital for optimal cancer treatment. Amide proton
transfer (APT), a chemical exchange saturation transfer
(CEST) technique, has been reported to show changes in
brain tumors, but amine proton exchange from endogenous
metabolites and free proteins/peptides side chains can
also be a major contributor to CEST signal. In this
work, we show how differences in amine proton exchange
may be used to differentiate breast cancer cells with
different malignant potential and conclude that amine
proton may function as a new endogenous biomarker for
non-invasively evaluating malignancy of breast cancer
cells.
|
|
|
Monday 1 June 2015
Exhibition Hall |
10:45 - 12:45 |
|
|
|
1130. |
Assessment of Tumor
Morphology on Diffusion-Weighted Breast MRI: Diagnostic
Value of Reduced FOV High Resolution Diffusion-Weighted
Imaging
Maarten W. Barentsz1, Valentina Taviani2,
Jung M. Chang3, Debra M. Ikeda2,
Kanae K. Myiake4, Suchandrima Banerjee5,
Maurice A.A.J. van den Bosch1, Brian A.
Hargreaves2, and Bruce L. Daniel2
1Radiology, University Medical Center
Utrecht, Utrecht, Netherlands, 2Radiology,
Stanford University, Stanford, CA, United States, 3Radiology,
Seul National University Hospital, Seul, Korea,4Diagnostic
Imaging and Nuclear Medicine, Kyoto University Hospital,
Kyoto, Japan, 5Global
Applied Science Laboratory, GE Healthcare, Menlo Park,
CA, United States
The diagnostic value of reduced FOV (r-FOV) high
resolution diffusion-weighted imaging (DWI) in
discriminating between benign and malignant breast
lesions was assessed with respect to conventional,
bilateral (bil) DWI and contrast-enhanced (CE) MRI. The
discriminatory ability of r-FOV based on ADC was similar
to bil-DWI. The area under the receiver operating
characteristics for the predictive value of lesion shape
and BI-RADS classification was higher when r-FOV DWI was
used instead of bil-DWI. CE-MRI alone had a higher
predictive value for malignancies than both r-FOV and
bil-DWI. High-resolution DWI of targeted lesions allowed
more accurate evaluation of tumor morphology than
bil-DWI.
|
1131. |
DW-PSIF in Breast MRI
Catherine J Moran1, Jung Min Chang2,
Marcus T Alley1, Kanae Kawai Miyake1,
Debra M Ikeda1, Brain A Hargreaves1,
Kristin L Granlund1, and Bruce L Daniel1
1Radiology, Stanford University, Stanford,
CA, United States, 2Seoul
National University Hospital, Seoul, Korea
The DW-PSIF sequence may provide an alternative to
EPI-DWI acquisitions for diffusion weighted MRI in the
breast as it provides diffusion weighted images with
higher resolution and none of the characteristic
distortion of EPI-DWI. We performed a pilot study of
DW-PSIF in the breast which included analysis of effect
on diagnostic accuracy and assessment of diffusion
weighting, sharpness, SNR, distortion and level of
artifact.
|
1132. |
Breast Tumors
Characterization using Diffusion Kurtosis Imaging
Yongming Dai1, Junxiang Zhang2,
and Dongmei Wu3
1Philips Healthcare, Shanghai, China, 2Department
of Radiology, The First Affiliated Hospital of Bengbu
Medical College, Anhui, China, 3Shanghai
Key Laboratory of Magnetic Resonance, East China Normal
University, Shanghai, China
In this abstract we investigated and evaluated the role
of magnetic resonance (MR) diffusion kurtosis imaging
(DKI) in characterizing breast lesions, and demonstrate
the potential utility of DKI for the characterization of
breast lesions.
|
1133. |
Novel Dynamic Contrast
Enhanced Breast MRI with High Spatiotemporal Resolution and
Fat Separation: Image Quality Compared to the Clinical
Standard-of-Care MRI
Roberta M Strigel1,2, Courtney K Morrison2,
Leah C Henze Bancroft1, James H Holmes3,
Kang Wang3, Wendy B DeMartini1,
Alejandro Munoz del Rio1,2, and Frank R
Korosec1,2
1Radiology, University of Wisconsin, Madison,
WI, United States, 2Medical
Physics, University of Wisconsin, Madison, WI, United
States, 3Global
MR Applications and Workflow, GE Healthcare, Madison,
WI, United States
High spatiotemporal resolution (STR) breast MRI offers
the potential to improve diagnostic accuracy and
characterization of cancer. We utilized a novel approach
to sampling k-space and reconstructing images with
view-sharing to provide high STR MRI with a temporal
resolution of 27 seconds, six-times faster than the
clinical standard-of-care, while maintaining high
spatial resolution. We performed an intra-patient study
to compare image quality between exams. Image quality of
the high STR MRI was affected by the higher parallel
imaging factor; however, differences were small and
diagnostic image quality was maintained. This technique
is promising for allowing advanced analysis of
perfusion.
|
1134. |
MRI Functional Parameters
in Breast Cancer:T2*, ADC and Contrast Agent Uptake
Evanthia Kousi1, Maria A. Schmidt1,
Marco Borri1, Cheryl Richardson2,
Georgina Hopkinson2, Elizabeth A.M. O'Flynn1,
Robin M. Wilson2, Steven Allen2,
Romney J.E. Pope2, and Martin O. Leach1
1CR-UK and EPSRC Imaging Centre, Royal
Marsden NHS Foundation Trust and Institute of Cancer
Reasearch, Sutton, Surrey, United Kingdom, 2Department
of Radiology, Royal Marsden NHS Foundation Trust,
Chelsea, London, United Kingdom
T2* relaxation time has been proposed as an imaging
biomarker to evaluate hypoxia associated with tumour
grade and therapeutic response. In this study, we
explore the relationship between T2*, ADC and contrast
agent uptake. Substantial variations for all functional
parameters detected within tumours. Considerable
inter-subject variability observed in the association
between T2* and ADC for breast tumours. Less variability
observed in the association between T2* and contrast
uptake. Considering all patients, T2* and ADC correlated
weakly and no correlation observed between T2* and
contrast uptake. Our results suggest that T2* is an
independent parameter and may provide new clinical
information.
|
1135. |
Magnetization Transfer
Ratio variations in malignant breast lesions and parenchyma
Andrew J Patterson1, Mary M McLean2,
Reem Bedair1, Andrew N Priest1,
John R Griffiths2, Martin J Graves1,
and Fiona J Gilbert1
1Department of Radiology, Cambridge
University Hospitals NHS Foundation Trust, Cambridge,
England, United Kingdom, 2Cancer
Research UK Cambridge Insititute, Li Ka Shing Cambridge,
Cambridge, England, United Kingdom
Magnetization Transfer Ratio (MTR) quantifies the
interactions of water protons with different
macromolecular environments. This study reports on
changes in MTR in tissue proximal to malignancy and
investigates the differences in MTR between tumor type
and grade. Thirty patients with biopsy confirmed breast
cancer were recruited. MTR maps are computed at 3T
following a B1 field correction. This study noted a
statistically significant difference between tumor type
with the invasive mucinous type having lower MTR. This
study finds that parenchyma proximal to malignancy was
lower than that of contralateral parenchyma which may be
due to desmoplastic reactions.
|
1136. |
Evaluation of lipid
composition in patients with benign tissue and cancer using
multiple gradient echo MRI
Melanie Freed1,2, Pippa Storey1,2,
Alana Amarosa Lewin1, Melanie Moccaldi1,
Linda Moy1, and Sungheon G. Kim1,2
1Center for Biomedical Imaging, Department of
Radiology, NYU School of Medicine, New York, NY, United
States, 2Center
for Advanced Imaging Innovation and Research (CAI2R),
Dept. Radiology, NYU School of Medicine, New York, NY,
United States
Obesity is a known risk factor for developing breast
cancer. So far, there has not been a comprehensive study
comparing the lipid composition in the breast for
patients with benign tissue and cancer. Part of the
reason this remains a challenge is the lack of methods
to non-invasively investigate lipid composition in
breast tissue. We use a multiple gradient echo
acquisition to rapidly acquire lipid spectral maps in
the breast. These data suggest that for post-menopausal
women, lower monounsaturated and higher saturated fatty
acids may be related to breast cancer development.
|
1137. |
Quantitative DCE Analysis
for Breast Imaging: The Benefit of Dixon Fat-Water
Separation in an ultrafast TWIST-VIBE Protocol
Elisabeth Weiland1, Sandra Peter2,
Dominik Nickel1, Rolf Janka2,
Michael Uder2, and Evelyn Wenkel2
1MR Application Developement, Siemens
Healthcare, Erlangen, Germany, 2Radiology,
University of Erlangen, Germany
We evaluated the potential of Dixon fat-water separation
using an ultrafast view sharing DCE protocol to
differentiate between benign and malignant lesions of
very early contrast phases. Analysis of maximum slope
(MS) and time-to-enhancement (TTE) of the kinetic curves
were performed on water-only images for 37 mass lesions.
Best differentiation was achieved with MS, derived from
the water-only images (ROC analysis with area under
curve of 0.914). Due to its short acquisition time and
its robust image quality ultrafast dual-echo sequences
with Dixon fat-water separation may be beneficial for
MR-based breast screening.
|
1138. |
Alterations to breast
tissue chemistry in women at risk of cancer: 2D MR
spectroscopy in vivo study
Jessica Buck1, Saadallah Ramadan1,
Leah Best2, Judith Silcock3,
Jameen Arm2, Scott Quadrelli1,
Gorane Santamaria1, Kin Men Leong2,
Peter Lau2, Peter Malycha1, David
Clark1,3, and Carolyn Mountford1,4
1Centre for MR in Health, University of
Newcastle, Newcastle, NSW, Australia, 2Calvary
Mater Hospital, Newcastle, NSW, Australia, 3The
Breast and Endocrine Centre, Gateshead, NSW, Australia, 4Centre
for Clinical Spectroscopy, Department of Radiology,
Brigham and Women's Hospital, Harvard Medical School,
Boston, MA, United States
In vivo 2D L-COSY identifies premalignant changes in
women at high risk of developing breast cancer that are
not seen by routine imaging, and allows women to be
identified as MR spectroscopy Low Risk or MR
spectroscopy High Risk according to changes recorded.
Changes in the MR spectroscopy High Risk group include
deregulation of lipid pathways and increased levels of
metabolites. If these changes are confirmed in larger
populations, it is possible that this information will
allow women at increased clinical risk for breast cancer
an objective means to monitor changes that may be taking
place in their breast tissue.
|
1139. |
Assessment of Background
Parenchymal Enhancement in Breast MRI of BRCA 1/2 Mutation
Carriers Compared to Matched Controls
Alana Amarosa Lewin1, Sungheon Kim1,
James S Babb1, Amy N Melsaether1,
Jason McKellop1, Melanie Moccaldi2,
Ana Paula Klautau Leite3, and Linda Moy1
1Radiology, New York University School of
Medicine, New York, New York, United States, 2Radiology,
New York University Cancer Institute, New York, New
York, United States, 3Radiology,
Hospital das Clínicas, School of Medicine, University of
São Paulo, Brazil
This study investigates whether quantitative kinetic
analysis of benign lesions and background parenchyma
(BP) in breast MRI can elucidate differences between
BRCA carriers and sporadic controls with high risk for
breast cancer. We identified 49 BRCA mutation carriers
and 49 control cases with benign lesions for comparison
of their initial and delayed enhancement ratios (IER and
DER) of BP. The control group showed significant
differences in IER and DER between pre and
post-menopausal women, but the BRCA group did not. Our
results also indicate that the BRCA gene mutation has
multifactorial and complex clinical and biologic
implications.
|
1140. |
A Practical Approach to
Pharmacokinetic Modelling in monitoring Neoadjuvant
Chemotherapy in Breast Cancer
Reem Bedair1, Andrew Patterson2,
Mary McLean3, Roie Manavaki1,
Scott Reid4, John Griffiths3,
Martin Graves2, and Fiona Gilbert1
1University of Cambridge, Department of
Radiology, Cambridge, Cambridgeshire, United Kingdom, 2Department
of Radiology, Cambridge University Hospitals NHS
Foundation Trust, Cambridge, Cambridgeshire, United
Kingdom, 3Cancer
Research UK Cambridge Research Institute, Cambridge,
Cambridgeshire, United Kingdom, 4GE
Healthcare, Diagnostic Imaging, Buckingham,
Buckinghamshire, United Kingdom
Quantitative DCE-MRI together with pharmacokinetic
modelling enables the assessment of tumour-vessel
permeability and leakage space in vivo. This work
compares the early changes in the PK-derived parameter
(Ktrans ) using both a voxel-wise histogram analysis
across the entire tumour and the average Ktrans from the
largest slice in cohort of breast cancer patients
undergoing neoadjuvant chemotherapy. Although
pixel-based analyses can demonstrate significant
differences in the distribution of Ktrans, this can be a
time-consuming process. Our results show that the
average Ktrans calculated from the single largest slice
provides statistically similar results that can be
easily incorporated into routine clinical practice.
|
1141. |
Characterization of
Invasive Breast Cancer using Quantitative DCE-MRI at 3.0T
Reem Bedair1, Martin Graves2, Mary
McLean3, Scott Reid4, Roie
Manavaki1, John Griffiths3, Andrew
Patterson2, and Fiona Gilbert1
1University of Cambridge, Department of
Radiology, Cambridge, Cambridgeshire, United Kingdom, 2Department
of Radiology, Cambridge University Hospitals NHS
Foundation Trust, Cambridge, Cambridgeshire, United
Kingdom, 3Cancer
Research UK Cambridge Research Institute, Cambridge,
Cambridgeshire, United Kingdom, 4GE
Healthcare, Diagnostic Imaging, Buckingham,
Buckinghamshire, United Kingdom
DCE-MRI has proven a promising non-invasive modality for
characterizing the pathophysiological microenvironment
of tumours. Pharmacokinetic modelling can yield results
of tumour-vessel permeability, perfusion and
extracellular-extravascular volume fraction. This work
exploits the improved spatiotemporal resolution
achievable at 3.0T to investigate the relationship
between the modelled vascular parameters and their
histopathological profile within a cohort of breast
cancer patients. Hotspot Ktrans and ve were found to be
higher for the more common malignant types. A
significant difference was found between hotspot Ktrans
and ve in grades 1 and 3 tumours. Our results indicate
that Ktrans and ve provide important and independent
information concerning tumor biology and microvascular
structure that supports the use of these more complex
analysis protocols.
|
1142. |
Influence of Breast Cancer
Receptor Status on Multi-parametric Magnetic Resonance
Imaging for Predicting Treatment Response: Preliminary
Results
Xia Li1, Vandana G Abramson1, Lori
R. Arlinghaus1, Hakmook Kang1,
Jason M Williams1, Richard G Abramson1,
A. Bapsi Chakravarthy1, Praveen Pendyala1,
and Thomas E Yankeelov1
1Vanderbilt University, Nashville, Tennessee,
United States
This study determines if classifying breast cancer
patients by subtype improves the ability of integrated
DCE-MRI and DW-MRI to predict eventual response after
the first cycle of NAC. The patients were divided into
three groups according to receptor status: 1)
ER-/PR-/HER2-, 2) HER2+, and 3) HR+/HER2-. These
preliminary results demonstrate that DCE- and DW-MRI may
be able to better predict treatment response for
patients with particular receptor status. This
observation should be confirmed in a large cohort in the
future.
|
1143. |
Does breast peritumoral
tissue hold valuable information for texture analysis?
Michael Fox1, Peter Gibbs1, Martin
Pickles1, and Lindsay W. Turnbull1
1Centre for MR Investigations, HYMS at
University of Hull, Hull, East Yorkshire, United Kingdom
The performance of GLCM texture analysis is dependent on
a well-drawn ROI segmenting a tumour from “healthy”
surrounding tissue. There may be changes to the
surrounding tissue in breast cancer patients which can
be an indicator of tumour status, or response
prediction. Software was developed to incrementally
expand the ROI for 100 patients and compare the
performance of GLCM texture analysis against previously
recorded values. An increase in number of differences
between TNEG patient sub-groups was found when
peritumoral tissue was included, and performance was
comparable for other patient sub-groups, suggesting
surrounding tissue should be included in analysis.
|
1144. |
The Association of Breast
Density with Tumor Subtypes: Evaluation with 3D MRI
Jeon-Hor Chen1,2, Yifan Li1, Yoon
Jung Choi3, Chen-Pin Chou4,
Tsung-Lung Yang4, and Min-Ying Su1
1Center for Functional Onco-Imaging,
University of California, Irvine, CA, United States, 2Department
of Radiology, Eda Hospital and I-Shou University,
Kaohsiung, Taiwan, 3Department
of Radiology, Kangbuk Samsung Hospital, Seoul, Korea, 4Department
of Radiology, Kaohsiung Veterans General Hospital,
Kaohsiung, Taiwan
Characterizing the association between breast density
and risk of tumor subtypes may enhance our understanding
of how breast cancer subtypes differ in etiology. The
goal of this study was to use 3D MR-based density method
to investigate the association of breast density with
the development of different subtypes of breast cancer.
In total 114 women diagnosed with unilateral breast
cancer were analyzed. A negative correlation between age
and percent breast density was noted, with older women
tended to have lower density. ER negative and triple
negative cancer had higher PD than other tumor subtypes,
but no statistical difference was identified.
|
1145. |
Minkowski Functionals in
MRI: A new texture analysis tool in breast MRI
Michael Fox1, Peter Gibbs1, Martin
Pickles1, and Lindsay W. Turnbull1
1Centre for MR Investigations, HYMS at
University of Hull, Hull, East Yorkshire, United Kingdom
Minkowski Functinals may provide a new method to observe
or diagnose breast cancer tumours in MRI, as they have
done in CT. Software was created in-house, using 101
threshold levels, to create binary images of segmented
breast lesions, from T1W MR images. Three 5th order
polynomial fits were created for each of the 100
patients to describe their change in MF values as the
threshold was raised. Two-thirds of the measured
parameters were able to distinguish between TNEG patient
sub-groups, with differences between biopsy grades being
found also. This work supports the introduction of
Minkowski Functionals into MRI texture analysis.
|
1146. |
Estimation of Fat fractions
in Different Subtypes of Breast Cancer using in-vivo 1H MRS
Study
Khushbu Agarwal1, Uma Sharma1,
Smriti Hari2, Vurthaluru Seenu3,
Rajinder Parshad3, and Naranamangalam R
Jagannathan1
1Department of NMR & MRI Facility, All India
Institute of Medical Sciences, New Delhi, Delhi, India, 2Department
of Radiodiagnosis, All India Institute of Medical
Sciences, New Delhi, Delhi, India, 3Department
of Surgical Disciplines, All India Institute of Medical
Sciences, New Delhi, Delhi, India
Fat fractions were calculated in different molecular
subtypes of breast cancer based on ER, PR and Her2neu
status. It was demonstrated that lipid content is
associated with hormone receptor status of breast cancer
patients. Our results showed a significant increase in
fat fraction of ER-/PR- and Her2neu+ than ER+/PR+ and
Her2neu- breast tumors. Highly proliferating tumors like
ER-, PR- and Her2neu+ breast cancers require more fat
for membrane production. The results obtained in the
present study signifies that studying lipid content of
different breast cancer subtypes might help in
therapeutic planning of these patients.
|
|
|
Monday 1 June 2015
Exhibition Hall |
10:45 - 12:45 |
|
|
|
1147. |
Rapid quantitative
T2-mapping of the prostate using 3D Dual Echo Steady State (DESS)
Isabel Dregely1, Daniel AJ Margolis2,
Kyung Sung1, Novena Rangwala1,
Steve Raman3, and Holden H Wu1
1Radiological Sciences, University of
California Los Angeles, Los Angeles, CA, United States, 2University
of California Los Angeles, Los Angeles, CA, United
States, 3University
of California Los Angeles, CA, United States
The central component of prostate cancer MRI is a
high-resolution T2-weighted (T2w) acquisition.
Quantitative T2-mapping can provide added value, however
current methods are limited by compromises between
spatial resolution, 3D coverage, and scan time. In this
work we show initial results in a pilot patient study of
rapid, quantitative T2 MRI in ~1 min total scan time
using a 3D Dual Echo Steady State (DESS) acquisition.
|
1148.
|
Modelling tissue
microstructure in bone metastases from prostate cancer using
VERDICT MRI
Colleen Bailey1, Eleftheria Panagiotaki1,
Nina Tunariu2, Matthew R Orton3,
Veronica A Morgan3, Thorsten Feiweier4,
David J Hawkes1, Martin O Leach3,
David J Collins3, and Daniel C Alexander1
1Centre for Medical Image Computing,
University College London, London, United Kingdom, 2Radiology,
Royal Marsden NHS Foundation Trust and Institute of
Cancer Research, Sutton, United Kingdom, 3CR-UK
and EPSRC Cancer Imaging Centre, Institute of Cancer
Research and Royal Marsden NHS Foundation Trust, London,
United Kingdom, 4Healthcare
Sector, Siemens AG, Erlangen, Germany
Bone metastases in men with advanced prostate cancer
were examined by diffusion MRI with varying diffusion
times and gradient strengths. Data were fitted to
3-compartment models of diffusion that included a
perfusion compartment, an extracellular compartment and
an intracellular spherically-restricted compartment.
Data showed variation for points with the same b-value
but different diffusion time and were better explained
by a model incorporating restriction than either
conventional ADC or 2- or 3-compartment models with free
diffusion. Model parameters indicated a low perfusion
fraction (<10%), intracellular volume fraction 0.22-0.56
and a cell radius between 4.7-9.9 µm.
|
1149. |
A Novel Prostate MR
Elastography Technique Based on Image Similarity
Seyed Reza Mousavi1, Seyyed Mohammad Hesabgar2,
Timothy Scholl2,3, and Abbas Samani2,3
1Clinical Neurological Sciences, University
of Western Ontario, London, Ontario, Canada, 2Medical
Biophysics, University of Western Ontario, London,
Ontario, Canada, 3Robarts
Research Institute, London, Ontario, Canada
T2-weighted MR imaging is an evolving modality in
prostate cancer diagnosis. Although T2-weighted MRI has
a good sensitivity but it has low specificity. The
specificity of the T2-weighted MRI, however, may be
improved by calculating prostate tissue elasticity
distribution. Tissue elasticity properties are known to
be prostate cancer biomarkers. In this research project,
an MR elastography technique is proposed to reconstruct
tissue Young’s modulus with the aim of improving
T2-weighted MR imaging specificity. The proposed
technique only utilizes T2-weighted MR imaging
information and does not require any additional
peripheral devices. It also does not appreciably disrupt
the clinical flow.
|
1150. |
DCE-MRI appearance of
prostate after androgen deprivation therapy – preliminary
results
Lucy E Kershaw1,2, Andrew J McPartlin2,3,
and Ananya Choudhury2,3
1CMPE, The Christie NHSFT, Manchester, United
Kingdom, 2Institute
of Cancer Sciences, The University of Manchester,
Manchester, United Kingdom, 3Oncology,
The Christie NHSFT, Manchester, United Kingdom
SYNOPSIS
|
1151. |
Comparison of prostate
tumor volume delineation between multi-parametric MRI
sequences when planning for hypofractionated radiotherapy
Hugh Harvey1, Veronica Morgan2,
David Dearnaley3, Sharon Giles2,
Alison Macdonald2, Julia Murray3,
and Nandita deSouza1
1CRUK Cancer Imaging Centre, The Institute of
Cancer Research, Sutton, Surrey, United Kingdom, 2The
Royal Marsden NHS Foundation Trust, Surrey, United
Kingdom, 3Radiotherapy
& Imaging, The Institute of Cancer Research, London,
United Kingdom
Delineation of the tumor region-of interest is crucial
when planning boost doses of radiation therapy to a
dominant intraprostatic tumor nodule. Comparison of
prostatic tumor volume measurements defined on T2W
images, Apparent Diffusion Coefficient maps and Dynamic
Contrast Enhanced images in 16 patients due for
radiation dose-boosting to tumor revealed a significant
difference in measured volumes between the sequences,
with T2W-derived volumes being up to 48.7% larger than
DCE-derived volumes and therefore most useful in the
context of radiation therapy planning.
|
1152. |
Sensitive Detection of
Zinc(II) in the Prostate with a Gadolinium-Based MRI
Contrast Agent
Veronica Clavijo Jordan1,2, Christian Preihs1,
Shiuhwei Chen3, Shanrong Zhang1,
Wen-hong Li3, Neil Rofsky2, and
Dean Sherry1,4
1Advanced Imaging Research Center, UT
Southwestern Medical Center, Dallas, Texas, United
States, 2Department
of Radiology, UT Southwestern Medical Center, Dallas,
Texas, United States, 3Departments
of Cell Biology and of Biochemistry, UT Southwestern
Medical Center, Dallas, Texas, United States, 4Department
of Chemistry, UT Dallas, Texas, United States
Due to the lack of accuracy in current prostate cancer
testing methods, there is an increasing need for more
reliable tests to differentiate prostate cancer from
benign prostatic hyperplasia (BPH), prostatic
intraepithelial neoplasia, and/or inflammation. The
reported loss of zinc in prostate cancer offers a
potential mechanism to distinguish malignancy from the
other conditions. Here we introduce a gadolinium-based
sensor that can report the available zinc(II) present in
the prostate sensitively. We also report the role of
glucose in secreting zinc(II) in prostate secretory
cells.
|
1153. |
Bi-exponential diffusion
analysis in normal prostate and prostate cancer: transition
zone and peripheral zone considerations
Thiele Kobus1,2, Andriy Fedorov1,
Clare Tempany1, Robert Mulkern3,
Ruth Dunne1, and Stephan E. Maier1
1Radiology, Brigham and Women's Hospital,
Boston, Massachusetts, United States, 2Radiology,
Radboud UMC, Nijmegen, Netherlands, 3Radiology,
Children's Hospital, Boston, Massachusetts, United
States
We investigated the performance of the bi-exponential
fit for extended b-factor DWI (b=0 to 3500 s/mm2)
in discriminating between different tissues in prostate
imaging. The means of the fitted parameters, ADCfast,
ADCslow and
fslow (fraction
of ADCslow component),
were significantly different between normal tissue (PZ
and TZ) and tumor tissue in both PZ and TZ. There was
also a difference for fslow between
normal PZ and TZ (p<0.001). No differences in the
parameters were found between tumors in the PZ and TZ.
The increase of fslow in
tumor tissue might represent the occupation of the
luminal space by tumor cells.
|
1154. |
A Novel Computer-Assisted
Approach for Prostate Cancer Diagnosis on T2w MRI
Haibo Wang1, Satish viswanath2,
Asha Singanamalli3, and Anant Madabhushi4
1Case Western Reserve University, Cleveland
Heights, OHIO, United States, 2Biomedical
Engineering, Case Western Reserve University, Cleveland
Heights, OHIO, United States, 3Case
Western Reserve University, OHIO, United States, 4Biomedical
Engineering, Case Western Reserve University, OHIO,
United States
This paper presents a computerized approach to assist
radiologist for prostate cancer diagnosis on T2w MRI. It
detects prostate cancer more faster and more accurate
than the conventional computerized solutions. Novel
image processing and machine learning techniques are
successfully used in the approach.
|
1155. |
MRI-guided focal laser
ablation of prostate cancer: comparison of targeted and
ablated volumes
Holden H Wu1, Alan Priester2,3,
Shyam Natarajan2,3, Kyunghyun Sung1,
Daniel Margolis1, Warren Grundfest2,3,
Leonard Marks3,4, and Steven Raman1
1Radiological Sciences, University of
California Los Angeles, Los Angeles, CA, United States, 2Biomedical
Engineering, University of California Los Angeles, CA,
United States, 3Center
for Advanced Surgical and Interventional Technology
(CASIT), University of California Los Angeles, CA,
United States, 4Urology,
University of California Los Angeles, CA, United States
to add ...
|
1156. |
Pilot: MRI Differences
Associated with Dutasteride and Finasteride Treatments in
Patients with Low Risk Prostate Cancer
Olga Starobinets1,2, John Kornak3,
John Kurhanewicz1,2, and Susan M Noworolski1,2
1Radiology and Biomedical Imaging, UCSF, San
Francisco, CA, United States, 2Graduate
Group in Bioengineering, UC Berkeley, Berkeley, CA,
United States, 3Epidemiology
and Biostatistics, UCSF, San Francisco, CA, United
States
Majority of imaging parameters obtained during a
prostate mpMRI scan demonstrate a better separation
between low-grade cancerous and benign regions for
prostate tissues exposed to anti-androgen therapy.
Pretreatment with dutasteride or finasteride may
facilitate a better detection of low-grade prostate
cancer.
|
1157. |
Diagnostic performance of
68Ga-PSMA-PET/MRI versus 68Ga-PSMA-PET/CT in the evaluation
of lymph node and bone metastases of prostate cancer
Martin Thomas Freitag1, Jan Radtke1,2,
Boris Hadaschik2, Uwe Haberkorn3,
Heinz-Peter Schlemmer1, Matthias Roethke1,
and Ali Afshar-Oromieh3
1Department of Radiology, German Cancer
Research Center, Heidelberg, Baden-Wuerttemberg,
Germany, 2Department
of Urology, University hospital of Heidelberg,
Heidelberg, Baden-Wuerttemberg, Germany, 3Department
of Nuclear Medicine, University hospital of Heidelberg,
Heidelberg, Baden-Wuerttemberg, Germany
The recently introduced 68Gallium-PSMA-ligand is
regarded as a significant step forward in the diagnosis
of prostate cancer and its metastases for PET
examinations. Multiparametric PET/MR could be
advantageous over PET/CT to better delineate
PET-positive findings due to higher soft tissue
contrast. Here, we systematically compare the diagnostic
performance of multiparametric PET/MRI versus PET/CT
with focus on bone and lymph node metastases of prostate
cancer. PET-positive results were significantly
correlating between both methods indicating a strong
reliability of PET-measurements using 68Ga-PSMA-PET/MRI.
For the delineation of lymph nodes, PET/MRI was superior
to PET/CT whereas the conspicuity of bone metastases was
comparable.
|
1158. |
The influence of polyamines
on metabolite ratios in the prostate at 7 tesla
Mariska P Luttje1, Catalina S Arteaga de
Castro2, Peter R Luijten1, Marco
van Vulpen1, Uulke A van der Heide2,
and Dennis WJ Klomp1
1Imaging Division, University Medical Center
Utrecht, Utrecht, Netherlands, 2Department
of Radiotherapy, the Netherlands Cancer Institute -
Antoni van Leeuwenhoek hospital, Amsterdam, Netherlands
In contrast to 1H MRSI at lower field strength, where
polyamine signals overlap with choline signals, our
results at 7 tesla demonstrate the ability to fit each
of the prostate metabolite resonances distinctively.
This facilitated investigation of the role of polyamines
in the results of 1H MRSI in detecting prostate cancer.
The conventional metabolite ratio (tCho+PA+Cr)/Cit
significantly discriminates between tumor and healthy
tissue areas at 7 tesla, whereas the new ratio
tCho/(Cit+PA+Cr) performs less in discriminating tumor
from healthy tissue in the prostate in contrast to
reports obtained from tissue samples.
|
1159. |
Clinical Assessment of B1+
Inhomogeneity Effects on Quantitative Prostate MRI at 3.0 T
Xinran Zhong1,2, Novena Rangwala1,
Steven Raman1, Daniel Margolis1,
Holden Wu1,2, and Kyunghyun Sung1,2
1Radiological Sciences, University of
California Los Angeles, Los Angeles, CA, United States, 2Biomedical
Physics Interdepartmental Program, University of
California Los Angeles, Los Angeles, CA, United States
B1+ variations in the pelvis is measured using the
reference region VFA method and differences on the T1
relaxation values in prostate and pelvic muscles with
and without compensating for B1+ variation were analyzed
in a total of 108 prostate patients at 3T. Significant
improvement on T1 value could be seen after RF
correction through comparison between different tissues
and different systems, indicating the need for B1
correction in prostate T1 imaging.
|
1160. |
Validation of Real time
Virtual Sonography (RVS) for targeted MR-ultrasound guided
transrectal prostate biopsies against transperineal template
saturation biopsies for service development
Victoria Sherwood1, Donald MacDonald2,
James Harding3, Nicholas Hedley3,
Kieran Jefferson2, Chris Koller1,
and Charles Hutchinson3
1Department of Radiology Physics, University
Hospitals Coventry & Warwickshire NHS Trust, Coventry,
Warwickshire, United Kingdom, 2Department
of Urology, University Hospitals Coventry & Warwickshire
NHS Trust, Coventry, Warwickshire, United Kingdom, 3Department
of Radiology, University Hospitals Coventry &
Warwickshire NHS Trust, Coventry, Warwickshire, United
Kingdom
A clinical development study was designed to validate
targeted MR-ultrasound fusion-guided prostate biopsies
against transperineal template saturation biopsies,
using Real-time Virtual Sonography (RVS). Twenty-seven
patients underwent fusion and template biopsies. Results
were compared and related back to multiparametric MRI.
Eleven of 19 patients with Gleason 6 disease or above,
as diagnosed by template biopsy, tested positive on
fusion biopsy. Almost all the remaining patients had
Gleason 6 disease, which may not be detected on MRI. RVS
has the potential to reduce patient complications and
lighten the burden on healthcare services by
significantly limiting the number of necessary template
saturation biopsies.
|
1161. |
T2-weighted 3D
Variable-Flip Angle Turbo Spin Echo Compared to Standard 2D
T2-weighted Imaging at 3T for Prostate Cancer Detection in a
Patient Cohort Undergoing MR/US fusion biopsy
Steven M Shea1, Joseph M Yacoub1,
Gopal N Gupta2, Grace Yoon3, and
Ari Goldberg1
1Radiology, Loyola University Chicago,
Maywood, IL, United States, 2Urology,
Loyola University Chicago, Maywood, IL, United States, 3Stritch
School of Medicine, Loyola University Chicago, Maywood,
IL, United States
The rise of MR/US fusion for prostate cancer biopsies
necessitates a true 3D imaging technique. We compared a
T2-weighted 3D variable flip angle turbo spin echo
acquisition versus the standard 2D T2-weighted
acquisition in patients undergoing MR/US fusion biopsy
at 3T. PIRADS scores, image quality scores, and relative
contrast were all equivalent or better in T2w 3D as
compared to T2w 2D. Given the advantages in scan time
and overall voxel size, T2w 3D imaging is a viable
alternative to T2w 2D imaging.
|
1162. |
In Vivo Sodium
Imaging of Human Prostate Cancer
Justin Charles Peterson1, Adam Farag2,
Trevor Szekeres2, Eli Gibson2,3,
Aaron D Ward2,3, Joseph Chin4,
Stephen Pautler5, Glenn Bauman4,
Cesare Romagnoli4, Robert Bartha1,2,
and Timothy J Scholl1,2
1Medical Biophysics, Western University,
London, Ontario, Canada, 2Robarts
Research Institute, Ontario, Canada, 3Biomedical
Engineering, Western University, Ontario, Canada, 4London
Health Sciences Centre, Ontario, Canada, 5St.
Joseph's Health Care, Ontario, Canada
Prostate cancer (PCa) is the most common malignancy in
men. Currently, a combination of multi-parametric MR
including T2-weighted,
diffusion-weighted, and dynamic contrast enhanced
imaging, is used clinically but often provides
insufficient information to determine the malignancy of
a lesion. Previous studies have shown increased MRI
measured tissue sodium concentration (TSC) in brain and
breast cancer. In this report we demonstrate in
vivo 23Na
MRI in patients with PCa. Using this proposed method TSC
data was registered to histopathology and analyzed.
These preliminary data show a positive correlation
between tumor grade and TSC within the prostate.
|
1163. |
Initial Evaluation of T2
Shine-Through Elimination with Relax DWI
Paul Summers1, Daniel Chong2,
Valentina Elli3, Daniele Giardiello4,
Mehran Vaziri1, Giuseppe Petralia1,
and Massimo Bellomi1,3
1European Institute of Oncology, Milan,
Italy, 2Stillpig
Software, Sarawak, Malaysia, 3University
of Milan, Milan, Italy, 4University
of Milan - Bicocca, Milan, Italy
Tissues with long T2s like the prostatic peripheral zone
(PZ) can mimic lesions in diffusion weighted MRI due to
“T2 shine-through”. We have evaluated the impact on
prostate tumor contrast of Relax DWI, where four or more
echo time and diffusion weighting combinations are used
to isolate T2 and ADC effects. Relax DWI showed better
contrast between tumor and both prostate and peripheral
zone when high b-value images were calculated for TE=0
(eliminating T2 effects) than was observed in the
acquired images using our scanner’s minimum TE for the
same b-value, without significant change in ADC map
appearance.
|
1164. |
Using Multiparametric MRI
to Differentiate Prostate Cancer in the Anterior Aspect of
the Gland
Olga Starobinets1,2, Jeffry Simko3,4,
Kyle Kuchinsky3, Sonam Machingal1,
John Kurhanewicz1,2, Peter R Carroll4,
Kirsten L Greene4, and Susan M Noworolski1,2
1Radiology and Biomedical Imaging, UCSF, San
Francisco, CA, United States, 2Graduate
Group in Bioengineering, UC Berkeley, Berkeley, CA,
United States, 3Pathology,
UCSF, San Francisco, CA, United States, 4Urology,
UCSF, San Francisco, CA, United States
The purpose of this study was to use semi-quantitative
parameters derived from dynamic contrast-enhanced (DCE)
MRI, 1hydrogen-MR spectroscopic imaging (MRSI),
diffusion MR and MRI to differentiate benign and
malignant, as well as high-risk from low-risk prostate
cancers in the anterior aspect of the prostate using
whole-mount pathology as the standard of reference. A
logistic regression combination of parameters provided
ROC AUC=0.983 for discriminating benign from malignant
tissues and AUC=0.824 for distinguishing between
low-risk and high-risk cancer.
|
1165. |
Validation of T2 mapping
for treatment response monitoring in longitudinal
multi-center clinical trials
Petra J van Houdt1, Harsh K Agarwal2,3,
Laurens B van Buuren1, Marko Ivancevic4,
Søren Haack5, Jesper Folsted Kallehauge6,
Peter L Choyke3, and Uulke A van der Heide1
1Radiation Oncology, the Netherlands Cancer
Institute, Amsterdam, Netherlands, 2Philips
Research NA, Briarcliff Manor, MD, United States, 3National
Cancer Institute, National Institutes of Health,
Bethesda, NY, United States, 4Philips
Healthcare, Best, Netherlands, 5Clinical
Engineering, Aarhus University Hospital, Aarhus,
Denmark, 6Medical
Physics, Aarhus University Hospital, Aarhus, Denmark
T2 is proposed as a biomarker for response monitoring of
patients with prostate cancer treated with radiotherapy.
A key requirement in multi-center longitudinal studies
is good reproducibility over multiple visits. The
purpose of this study was to establish the inter- and
intra-center reproducibility of T2 maps. Phantom
measurements were performed on three platforms, showing
that the differences in T2 values within and between
platforms were smaller than 5%. Average difference in T2
values of volunteers between two visits was -1.5 +/-
9.5%. This work demonstrates that T2 mapping is suitable
for use in multi-center, longitudinal trials in prostate
cancer patients.
|
1166. |
A multi-site study to
develop a new pseudo-quantitative T2w MRI map for prostate
cancer characterization: Preliminary findings
Satish Easwar Viswanath1, Chun Yeung Yim2,
Nicolas Bloch3, Mark Rosen4, John
Kurhanewicz5, and Anant Madabhushi6
1Case Western Reserve University, Cleveland,
Ohio, United States, 2Rutgers
University, New Brunswick, New Jersey, United States, 3Boston
University, MA, United States, 4University
of Pennsylvania, PA, United States, 5University
of California San Francisco, CA, United States, 6Case
Western Reserve University, Ohio, United States
We present the first results of a multi-site study
involving post-processing T2w MRI acquisitions from
multiple institutions and scanners, to calculate a new
pseudo-quantitative T2w parameter with tissue-specific
meaning, to more accurately and reproducibly identify
prostate cancer on MRI.
|
1167. |
Diagnostic performance of
the ESUR PI-RADS scoring system for multiparametric MRI of
the prostate: systematic comparison of four parameters
versus three parameters for detection and grading of
prostate cancer
Stephan Polanec1, Katja Pinker2,
Martin Suasani2, Peter Brader2,
Dietmar Georg2, Thomas Helbich2,
and Pascal Baltzer2
1General Hospital of the Medical University
of Vienna!, Vienna, Vienna, Austria, 2General
Hospital of the Medical University of Vienna!, Vienna,
Austria
To compare the diagnostic performance of the ESUR
PI-RADS scoring system for multiparametric magnetic
resonance imaging (MP MRI) of the prostate using either
three (T2w, DCE, DWI) or four MRI parameters (T2w, DCE,
DWI, 3D 1H-MRSI) for the detection and grading of
prostate cancer (PCa). The results demonstrate that
diagnostic accuracy of MP MRI of the prostate using
three MRI parameters is as good as MP MRI of the
prostate using four MRI parameters. Adding 3D 1H-MRSI as
a fourth parameter doesn’t increase diagnostic accuracy
for differentiation of benign and malignant lesions or
of high-grade and low-grade PCa.
|
1168. |
Radiogenomics of Prostate
Cancer: Association Between Quantitative Multi-Parametric
MRI Features and PTEN Expression
Aytekin Oto1, David VanderWeele2,
Yulei Jiang1, Stephanie Maria McCann1,
Xiaobing Fan1, Jianing Wang1, and
Tatjana Antic3
1Radiology, The University of Chicago
Medicine, Chicago, IL, United States, 2Internal
Medicine, The University of Chicago Medicine, Chicago,
IL, United States, 3Pathology,
The University of Chicago Medicine, Chicago, IL, United
States
Multi-parametric MRI (Mp-MRI) is playing an increasing
role in the detection, staging and localization of Pca.
Determination of the cancer aggressiveness by Mp-MRI has
been addressed in several studies and significant
correlations between quantitative MRI parameters (such
as apparent diffusion coefficient [ADC] and ktrans) and
Gleason score have been reported. However, to our
knowledge, no study thus far has investigated
associations between quantitative Mp-MRI parameters and
genomic markers in Pca.
|
1169. |
The Application of Sparse
Reconstruction to High Spatio-Temporal Resolution Dynamic
Contrast Enhanced MRI of the Prostate: Initial Clinical
Experience with Effect on Image and Parametric Perfusion
Characteristic Quality
Adam T. Froemming1, Eric A. Borisch2,
Joshua D. Trzasko2, Roger C. Grimm2,
Armando Manduca2, Phillip Young3,
Stephen J. Riederer3, and Akira Kawashima3
1Radiology, Mayo Clinic, Rochester, MN,
United States, 2Physiology
and Biomedical Engineering, Mayo Clinic, MN, United
States, 3Radiology,
Mayo Clinic, MN, United States
We studied the application of an iterative image
reconstruction technique (ADMM) applied to our high
temporal resolution DCE sequence (pCAPR) for prostate
imaging, compared to the conventional reconstruction.
This was done both subjectively with independent reader
ratings of image quality characteristics, and
objectively with measurement of quantitative perfusion
data from ROI of lesions.
|
|
|
Monday 1 June 2015
Exhibition Hall |
10:45 - 12:45 |
|
|
|
1170. |
Pre-operative T stage
evaluation of esophageal carcinoma: a comparison study
between self-gating radial VIBE and breath-hold VIBE
Fengguang Zhang1, Jinrong Qu1, Hui
Liu2, Xiang Li1, Hongkai Zhang1,
Hailiang Li1, Grimm Robert3,
Kiefer Berthold3, and Xuejun Chen1
1Radiology, Henan Tumor Hospital, Zhengzhou,
Henan, China, 2NEA
MR Collaboration, Siemens Ltd., China, Shanghai, China, 3Healthcare,
Siemens AG, Erlangen, Germany
Accurate staging esophageal carcinoma is quite important
for treatment decision. un to now, there is still no
available MRI technique to well address this need. With
the development of self-gating radial VIBE, we are able
to evaluate this new technqiue in a large esophageal
carcinoma population. The prelimary results shows
confident in T1 and T2 staging.
|
1171. |
Isotropic Diffusion
Spectrum Imaging Constrained by Independent Component
Analysis with a Ball and Stick Model to Assess Cellularity
of Brain Tumors
JEONG-WON JEONG1,2, Csaba Juhász1,3,
Sandeep Mittal3,4, Edit Bosnyák1,
and Diane C Chugani1,2
1Pediatrics and Neurology, Wayne State
University, Detroit, MI, United States, 2Children's
Hospital of Michigan, Detroit, MI, United States, 3Karmanos
Cancer Institute, Detroit, MI, United States, 4Neurosurgery
and Oncology, Wayne State University, Detroit, MI,
United States
An independent component analysis with ball-stick model
(ICA+BSM) was proposed to solve an intra-voxel crossing
fiber problem in clinical diffusion tensor imaging
(DTI). This study investigates whether the ICA+BSM
analysis can be combined with isotropic diffusion
spectrum imaging (IDSI) technique to assess the degree
of cellularity in tumor-infiltrated white matter tissues
in clinical DTI. Compared with apprarent diffusion
coefficient image, which provided a moderate accuracy of
0.457 to detect tumor cells in the active tumor region
delinated by á[11C]methyl-L-tryptophan (AMT)-positron
emission tomography, IDSI-derived cell ratio yielded a
much higher accuracy of 0.969 in conventional receiver
operating characteristic curve analysis.
|
1172. |
Comparison of intravoxel
incoherent motion characteristics between different tumor
stages and grades in rectal cancer
Hongliang Sun1, Yanyan Xu2, Aiping
Song3, and Wu Wang4
1Radiology, China-Japan Friendship Hospital,
Beijing, Beijing, China, 2Radiology,
China-Japan Friendship Hospital, Beijing, China, 3China-Japan-Friendship
Hospital, Beijing, China, 4China-Japan
Friendship Hospital, Beijing, China
We found the IVIM parameters demonstrated well
correlation with tumor stage and grade, which could
reflect clinicopathological features of rectal cancer.
|
1173. |
Whole body multi-parametric
MRI; A comparison of the diagnostic performance of different
sequences
Arash Latifoltojar1, Margaret Hall-Craggs2,
Alan Bainbridge2, Charles House2,
Kannan Rajesparan2, Stuart Taylor3,
Kwee Yong3, Neil Rabin2, and
Shonit Punwani3
1University College London, London, London,
United Kingdom, 2University
College London Hospital, London, United Kingdom, 3University
College London, London, United Kingdom
Whole body magnetic resonance imaging (WBMRI) is gaining
ground for initial staging and monitoring treatment
response of patients with multiple myeloma. However,
most of the reported WBMRI protocols are based on
anatomical MRI sequences such as pre-contrast T1
weighted, T2-weighted and short tau inversion recovery
(STIR). In this study, the diagnostic performance of
multiple anatomical and functional whole body MRI
sequences for detection of myelomatous bone marrow
involvement and its impact on Durie-Salmon PLUS staging
is investigated.
|
|
|